background	NN	ROOT
:	:	punct

patentee	NN	nsubj
bring	VBD	ROOT
action	NN	dobj
against	IN	prep
competitor	NN	pobj
,	,	punct
allege	VBG	advcl
that	IN	det
competitor	NN	poss
's	POS	case
filing	NN	nsubj
of	IN	prep
abbreviate	VBN	amod
new	JJ	amod
drug	NN	compound
application	NN	pobj
(	-LRB-	punct
ANDA	NNP	appos
)	-RRB-	punct
seek	VBG	acl
to	IN	aux
market	NN	xcomp
generic	JJ	amod
sublingual	JJ	amod
tablet	NN	nsubj
infringe	VBD	ccomp
patent	NN	dobj
for	IN	prep
method	NN	pobj
of	IN	prep
sublingually	RB	advmod
administer	VBG	pcomp
tablet	NN	dobj
and	CC	cc
patent	NN	conj
for	IN	prep
sublingual	JJ	amod
tablet	NN	pobj
use	VBN	acl
for	IN	prep
treatment	NN	pobj
of	IN	prep
opioid	NN	amod
dependence	NN	pobj
.	.	punct

the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	nsubj
for	IN	prep
the	DT	det
District	NNP	pobj
of	IN	prep
Delaware	NNP	pobj
,	,	punct
No.	SYM	compound
1:14-cv-00829-slr	CD	compound
-	HYPH	punct
SRF	NNP	appos
,	,	punct
Sue	NNP	compound
L.	NNP	compound
Robinson	NNP	conj
,	,	punct
J.	NNP	appos
,	,	punct
217	CD	nummod
F.Supp.3d	NNP	appos
756	CD	nummod
,	,	punct
grant	VBN	ROOT
judgment	NN	dobj
for	IN	prep
competitor	NN	pobj
in	IN	prep
part	NN	pobj
after	IN	prep
find	VBG	pcomp
at	IN	prep
bench	JJ	compound
trial	NN	pobj
that	WDT	mark
some	DT	det
claim	NNS	nsubj
of	IN	prep
one	CD	nummod
patent	NN	pobj
be	VBD	ccomp
invalid	JJ	acomp
on	IN	prep
ground	NN	pobj
of	IN	prep
obviousness	NN	pobj
.	.	punct

patentee	NN	nsubj
appeal	VBD	ROOT
.	.	punct

 	_SP	

the	DT	det
Court	NNP	nsubj
of	IN	prep
Appeals	NNPS	pobj
,	,	punct
Newman	NNP	conj
,	,	punct
Circuit	NNP	compound
Judge	NNP	npadvmod
,	,	punct
hold	VBD	ROOT
that	IN	mark
prior	JJ	amod
art	NN	nsubj
do	VBD	aux
not	RB	neg
suggest	VB	ccomp
selection	NN	dobj
and	CC	cc
combination	NN	conj
achieve	VBN	acl
by	IN	agent
inventor	NNS	pobj
in	IN	prep
sublingual	JJ	amod
drug	NN	compound
formulation	NN	pobj
that	WDT	nsubj
provide	VBD	relcl
improved	JJ	amod
treatment	NN	dobj
of	IN	prep
opioid	NN	amod
dependence	NN	pobj
.	.	punct

 	_SP	

Orexo	NNP	compound
AB	NNP	nsubj
and	CC	cc
Orexo	NNP	compound
US	NNP	compound
Inc.	NNP	conj
(	-LRB-	punct
collectively	RB	advmod
"	``	punct
Orexo	NNP	appos
"	''	punct
)	-RRB-	punct
appeal	VBP	ccomp
the	DT	det
decision	NN	dobj
of	IN	prep
the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	pobj
for	IN	prep
the	DT	det
District	NNP	pobj
of	IN	prep
Delaware	NNP	pobj
,	,	punct
hold	VBG	advcl
claim	NNS	dobj
1	CD	nummod
,	,	punct
3	CD	npadvmod
-	SYM	punct
6	CD	prep
,	,	punct
and	CC	cc
8	CD	nummod
-	SYM	punct
10	CD	prep
of	IN	prep
U.S.	NNP	compound
patent	NN	compound
No.	SYM	compound
8,940,330	CD	pobj
(	-LRB-	punct
"	``	punct
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	conj
"	''	punct
)	-RRB-	punct
invalid	JJ	ccomp
on	IN	prep
the	DT	det
ground	NN	pobj
of	IN	prep
obviousness.1	WP	nmod
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	pobj
,	,	punct
entitle	VBN	acl
"	``	punct
Abuse	NNP	compound
-	HYPH	punct
resistant	JJ	compound
Pharmaceutical	NNP	compound
Composition	NNP	oprd
for	IN	prep
the	DT	det
Treatment	NNP	pobj
of	IN	prep
Opioid	NNP	compound
Dependence	NNP	pobj
,	,	punct
"	''	punct
claim	VBZ	ROOT
a	DT	det
product	NN	dobj
have	VBG	acl
the	DT	det
brand	NN	compound
name	NN	dobj
Zubsolv	NNP	compound
(r)	SYM	appos
,	,	punct
approve	VBN	acl
by	IN	agent
the	DT	det
FDA	NNP	pobj
for	IN	prep
treatment	NN	pobj
of	IN	prep
opioid	NN	amod
dependence	NN	pobj
.	.	punct

 	_SP	

Actavis	NNP	compound
Elizabeth	NNP	compound
LLC	NNP	nsubj
(	-LRB-	punct
"	``	punct
Actavis	NNP	appos
"	''	punct
)	-RRB-	punct
file	VBD	ROOT
an	DT	det
Abbreviated	NNP	compound
New	NNP	compound
Drug	NNP	compound
Application	NNP	dobj
(	-LRB-	punct
"	``	punct
ANDA	NNP	appos
"	''	punct
)	-RRB-	punct
for	IN	prep
a	DT	det
generic	JJ	amod
counter	NN	subtok
-	NN	subtok
part	NN	pobj
of	IN	prep
Zubsolv	NNP	pobj
,	,	punct
accompany	VBN	advcl
by	IN	agent
a	DT	det
Paragraph	NNP	compound
IV	NNP	compound
certification	NN	pobj
,	,	punct
lead	VBG	conj
to	IN	prep
this	DT	det
Hatch	NNP	compound
-	HYPH	punct
Waxman	NNP	compound
litigation	NN	pobj
in	IN	prep
accordance	NN	pobj
with	IN	prep
21	CD	nummod
U.S.C.	NNP	pobj
¡±	NNP	nummod

355(j	CD	ROOT
)	-RRB-	punct
and	CC	cc
35	CD	nummod
U.S.C.	NNP	nmod
¡±	CD	nummod
271(e)(2)(a	CD	conj
)	-RRB-	punct
.	.	punct

two	CD	nummod
Orexo	NNP	compound
patent	NNS	nsubjpass
be	VBD	auxpass
challenge	VBN	ROOT
by	IN	agent
Actavis	NNP	pobj
,	,	punct
but	CC	cc
U.S.	NNP	compound
patent	NN	compound
No.	SYM	nsubj
8,454,996	CD	nummod
(	-LRB-	punct
"	``	punct
the	DT	det
'	``	punct
996	CD	nummod
patent	NN	appos
"	''	punct
)	-RRB-	punct
,	,	punct
entitle	VBN	conj
"	``	punct
Pharmaceutical	NNP	compound
Composition	NNP	nsubjpass
for	IN	prep
the	DT	det
Treatment	NNP	pobj
of	IN	prep
Acute	NNP	compound
Disorders	NNPS	pobj
,	,	punct
"	''	punct
which	WDT	nsubjpass
be	VBD	auxpass
hold	VBN	relcl
valid	JJ	oprd
in	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
,	,	punct
be	VBZ	auxpass
not	RB	neg
involve	VBN	oprd
in	IN	prep
this	DT	det
appeal	NN	pobj
.	.	punct

 	_SP	

-PRON-	PRP	nsubj
reverse	VBP	ROOT
the	DT	det
judgment	NN	dobj
of	IN	prep
invalidity	NN	pobj
of	IN	prep
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	pobj
,	,	punct
for	IN	mark
-PRON-	PRP	nsubj
conclude	VBP	advcl
that	DT	mark
obviousness	NN	nsubjpass
be	VBD	auxpass
not	RB	neg
prove	VBN	ccomp
by	IN	agent
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
.	.	punct

 	_SP	

the	DT	det
'	``	punct
330	CD	nummod
patent	NN	ROOT

 	_SP	

the	DT	det
'	``	punct
330	CD	nummod
patent	NN	compound
specification	NN	nsubj
explain	VBZ	ROOT
that	IN	mark
opioid	NN	npadvmod
-	HYPH	punct
base	VBN	amod
pharmaceutical	NN	compound
product	NNS	nsubj
intend	VBN	acl
for	IN	prep
the	DT	det
relief	NN	pobj
of	IN	prep
pain	NN	pobj
have	VBP	aux
become	VBN	ccomp
a	DT	det
source	NN	attr
of	IN	prep
addiction	NN	pobj
,	,	punct
dependency	NN	conj
,	,	punct
and	CC	cc
abuse	NN	conj
.	.	punct

treatment	NN	nsubj
for	IN	prep
opioid	NN	amod
addiction	NN	pobj
include	VBZ	ROOT
a	DT	det
protocol	NN	dobj
call	VBN	acl
"	``	punct
substitution	NN	compound
therapy	NN	oprd
,	,	punct
"	''	punct
where	WRB	advmod
partial	JJ	nsubj
opioid	NN	relcl
agonists2	JJ	dobj
that	WDT	nsubj
have	VBP	ccomp
high	JJR	amod
bind	VBG	amod
affinity	NNS	dobj
at	IN	prep
opioid	NN	amod
receptor	NNS	pobj
but	CC	cc
produce	VBP	conj
lower	VBN	amod
dependency	NN	dobj
than	IN	prep
full	JJ	amod
agonist	NNS	pobj
like	IN	prep
heroin	NN	pobj
,	,	punct
can	MD	aux
lead	VB	conj
to	IN	prep
cessation	NN	pobj
of	IN	prep
addiction	NN	pobj
by	IN	prep
relieve	VBG	pcomp
the	DT	det
opioid	NN	amod
craving	NN	dobj
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	nsubj
show	VBZ	nsubj
use	VBP	ROOT
for	IN	prep
this	DT	det
purpose	NN	pobj
of	IN	prep
the	DT	det
partial	JJ	amod
agonist	NN	compound
buprenorphine	NN	pobj
,	,	punct
administer	VBN	acl
in	IN	prep
sublingual	JJ	amod
tablet	NNS	pobj
and	CC	cc
in	IN	conj
oral	JJ	amod
film	NNS	pobj
.	.	punct

 	_SP	

the	DT	det
'	``	punct
330	CD	nummod
patent	NN	nsubj
explain	VBZ	ROOT
that	IN	mark
while	IN	mark
buprenorphine	NN	nsubj
have	VBZ	advcl
less	RBR	advmod
narcotic	JJ	amod
effect	NN	dobj
than	IN	prep
a	DT	det
full	JJ	amod
opioid	NN	pobj
,	,	punct
addict	NNS	nsubjpass
be	VBD	auxpass
know	VBN	ccomp
to	TO	aux
dissolve	VB	xcomp
the	DT	det
buprenorphine	NN	dobj
from	IN	prep
the	DT	det
substitution	NN	compound
therapy	NN	compound
tablet	NN	pobj
,	,	punct
and	CC	cc
inject	VB	conj
the	DT	det
dissolve	VBN	amod
buprenorphine	NN	dobj
intravenously	RB	advmod
to	TO	aux
achieve	VB	xcomp
an	DT	det
enhanced	JJ	amod
opioid	NN	amod
effect	NN	dobj
.	.	punct

to	TO	aux
counteract	VB	advcl
this	DT	det
abuse	NN	dobj
,	,	punct
-PRON-	PRP	nsubjpass
be	VBD	auxpass
know	VBN	ROOT
to	TO	aux
combine	VB	xcomp
buprenorphine	NN	dobj
with	IN	prep
the	DT	det
opioid	NN	amod
antagonist3	NN	pobj
naloxone	RB	advcl
in	IN	prep
substitution	NN	compound
therapy	NN	pobj
.	.	punct

 	_SP	

-PRON-	PRP	nsubjpass
be	VBD	auxpass
know	VBN	ROOT
that	IN	mark
formulation	NNS	nsubj
contain	VBG	acl
buprenorphine	NN	dobj
to	IN	prep
naloxone	NN	pobj
at	IN	prep
a	DT	det
ratio	NN	pobj
of	IN	prep
4:1	CD	pobj
provide	VBP	ccomp
the	DT	det
therapeutically	RB	advmod
optimal	JJ	amod
balance	NN	dobj
for	IN	prep
sublingual	JJ	amod
treatment	NN	pobj
.	.	punct

naloxone	NN	nsubj
have	VBZ	ROOT
poor	JJ	amod
transmucosal	NN	compound
bioavailability	NN	dobj
so	IN	mark
that	IN	mark
if	IN	mark
the	DT	det
mixture	NN	nsubjpass
be	VBZ	auxpass
take	VBN	advcl
in	IN	prep
tablet	NN	compound
form	NN	pobj
as	IN	mark
direct	VBN	advcl
,	,	punct
the	DT	det
buprenorphine	NN	nsubj
will	MD	aux
act	VB	advcl
as	IN	mark
intend	VBN	advcl
to	TO	aux
treat	VB	xcomp
opioid	JJ	amod
dependence	NN	dobj
with	IN	prep
little	JJ	amod
interference	NN	pobj
from	IN	prep
the	DT	det
naloxone	NN	pobj
.	.	punct

however	RB	advmod
,	,	punct
if	IN	mark
the	DT	det
tablet	NN	nsubjpass
be	VBZ	auxpass
dissolve	VBN	advcl
and	CC	cc
inject	VBN	conj
,	,	punct
the	DT	det
naloxone	NN	nsubj
will	MD	aux
antagonize	VB	ROOT
the	DT	det
effect	NNS	dobj
of	IN	prep
the	DT	det
buprenorphine	NN	pobj
,	,	punct
result	VBG	advcl
in	IN	prep
withdrawal	NN	compound
symptom	NNS	pobj
and	CC	cc
thus	RB	advmod
deter	VBG	conj
abuse	NN	dobj
of	IN	prep
the	DT	det
formulation	NN	pobj
.	.	punct

the	DT	det
4:1	CD	nummod
ratio	NN	nsubj
provide	VBZ	ROOT
for	IN	prep
appropriate	JJ	amod
pharmacological	JJ	amod
amount	NNS	pobj
of	IN	prep
naloxone	NN	pobj
to	TO	aux
deter	VB	advcl
abuse	NN	dobj
when	WRB	advmod
inject	VBN	advcl
,	,	punct
but	CC	cc
do	VBZ	aux
not	RB	neg
interfere	VB	conj
with	IN	prep
buprenorphine	NN	pobj
when	WRB	advmod
take	VBN	advcl
in	RP	prt
tablet	NN	compound
form	NN	dobj
.	.	punct
'	''	punct

330	CD	nummod
patent	NN	ROOT
,	,	punct
col.	NN	conj
2	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

13	CD	ROOT
-	SYM	punct
22	CD	prep
;	:	punct
-PRON-	PRP	appos

would	MD	subtok
.	.	ROOT
,	,	punct
col.	NN	npadvmod
9	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

37	CD	ROOT
-	SYM	punct
50	CD	prep
.	.	punct

however	RB	advmod
,	,	punct
naloxone	DT	poss
be	VBZ	case
"	``	punct
functional	JJ	amod
blockade	NN	nsubj
of	IN	prep
buprenorphine	NN	poss
's	POS	case
action	NN	pobj
be	VBZ	ROOT
also	RB	advmod
only	RB	advmod
partial	JJ	acomp
and	CC	cc
be	VBZ	conj
short	RB	advmod
-	HYPH	punct
lived	JJ	acomp
in	IN	prep
-PRON-	PRP$	poss
nature	NN	pobj
,	,	punct
"	``	punct
-PRON-	PRP	ccomp
would	MD	subtok
.	.	punct
,	,	punct
col.	NN	npadvmod
2	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

23	CD	ROOT
-	SYM	punct
25	CD	prep
,	,	punct

and	CC	cc
there	EX	expl
be	VBD	ROOT
a	DT	det
continue	VBG	amod
need	NN	attr
for	IN	prep
improvement	NN	pobj
in	IN	prep
substitution	NN	compound
therapy	NN	compound
formulation	NNS	pobj
.	.	punct

 	_SP	

the	DT	det
'	``	punct
330	CD	nummod
patent	NN	nsubj
be	VBZ	ROOT
for	IN	prep
a	DT	det
sublingual	JJ	amod
tablet	NN	compound
formulation	NN	pobj
that	WDT	nsubj
be	VBZ	relcl
less	RBR	advmod
subject	JJ	acomp
to	IN	prep
abuse	NN	pobj
.	.	punct

the	DT	det
formulation	NN	nsubj
enhance	VBZ	ROOT
the	DT	det
agonist	NN	amod
effectiveness	NN	dobj
of	IN	prep
buprenorphine	NN	pobj
,	,	punct
permit	VBG	advcl
a	DT	det
reduce	VBN	amod
amount	NN	dobj
of	IN	prep
buprenorphine	NN	pobj
in	IN	prep
the	DT	det
tablet	NN	pobj
and	CC	cc
thus	RB	advmod
reduce	VBG	conj
the	DT	det
amount	NN	dobj
available	JJ	amod
on	IN	prep
dissolving	NN	pcomp
and	CC	cc
inject	VBG	conj
the	DT	det
product	NN	dobj
.	.	punct

In	IN	prep
this	DT	det
formulation	NN	pobj
,	,	punct
microparticle	NNS	nsubjpass
of	IN	prep
buprenorphine	NN	pobj
be	VBP	auxpass
adhere	VBN	ROOT
to	IN	prep
the	DT	det
surface	NN	pobj
of	IN	prep
carrier	NN	compound
particle	NNS	pobj
of	IN	prep
citric	JJ	amod
acid	NN	pobj
,	,	punct
and	CC	cc
the	DT	det
formulation	NN	nsubj
also	RB	advmod
contain	VBZ	conj
naloxone	RB	dobj
in	IN	prep
the	DT	det
4:1	CD	nummod
ratio	NN	pobj
.	.	punct

the	DT	det
'	``	punct
330	CD	nummod
patent	NN	nsubj
explain	VBZ	ROOT
that	IN	mark
the	DT	det
buprenorphine	NN	nsubj
in	IN	prep
the	DT	det
microparticle	NNS	pobj
act	VBZ	ccomp
with	IN	prep
little	JJ	amod
interference	NN	pobj
from	IN	prep
the	DT	det
naloxone	NN	pobj
,	,	punct
but	CC	cc
if	IN	mark
the	DT	det
tablet	NN	nsubjpass
be	VBZ	auxpass
dissolve	VBN	advcl
in	IN	prep
water	NN	pobj
for	IN	prep
injection	NN	pobj
into	IN	prep
the	DT	det
bloodstream	NN	pobj
,	,	punct
the	DT	det
naloxone	NN	nsubjpass
will	MD	aux
also	RB	advmod
be	VB	auxpass
dissolve	VBN	conj
and	CC	cc
will	MD	aux
antagonize	VB	conj
buprenorphine	NN	poss
's	POS	case
effect	NNS	dobj
.	.	punct

 	_SP	

all	DT	det
party	NNS	nsubj
agree	VBP	ROOT
that	IN	mark
the	DT	det
product	NN	nsubj
in	IN	prep
the	DT	det
'	JJ	punct
330	CD	nummod
patent	NN	pobj
provide	VBZ	ccomp
improve	VBN	amod
treatment	NN	dobj
of	IN	prep
opioid	NN	amod
dependence	NN	pobj
,	,	punct
as	IN	prep
compare	VBN	prep
with	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

the	DT	det
'	``	punct
330	CD	nummod
patent	NN	compound
specification	NN	nsubj
include	VBZ	ROOT
datum	NNS	dobj
from	IN	prep
clinical	JJ	amod
trial	NNS	pobj
compare	VBG	acl
the	DT	det
related	JJ	amod
sublingual	JJ	amod
product	NN	dobj
Suboxone	NNP	compound
(r)	SYM	appos
.	.	punct

patent	NN	compound
Example	NNP	nsubj
2	CD	nummod
show	VBZ	ROOT
a	DT	det
66	CD	nummod
%	NN	compound
improvement	NN	dobj
in	IN	prep
bioavailability	NN	pobj
of	IN	prep
buprenorphine	NN	pobj
,	,	punct
and	CC	cc
Patent	NNP	compound
Examples	NNP	nsubj
7	CD	nummod
and	CC	cc
8	CD	conj
show	NN	conj
bioequivalent	JJ	amod
result	NNS	dobj
for	IN	prep
a	DT	det
sublingual	JJ	amod
tablet	NN	pobj
contain	VBG	acl
29	CD	nummod
%	NN	npadvmod
less	JJR	amod
buprenorphine	NN	dobj
than	IN	prep
in	IN	prep
Suboxone	NNP	compound
tablet	NNS	pobj
.	.	punct

 	_SP	

Actavis	NNP	nsubj
do	VBZ	aux
not	RB	neg
dispute	VB	ROOT
the	DT	det
improvement	NN	dobj
,	,	punct
or	CC	cc
-PRON-	PRP$	poss
value	NN	conj
in	IN	prep
treatment	NN	pobj
of	IN	prep
addiction	NN	pobj
.	.	punct

rather	RB	advmod
,	,	punct
Actavis	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
this	DT	det
formulation	NN	nsubj
be	VBZ	ccomp
obvious	JJ	acomp
base	VBN	prep
on	IN	prep
a	DT	det
combination	NN	pobj
of	IN	prep
reference	NNS	pobj
,	,	punct
and	CC	cc
that	DT	mark
improved	JJ	amod
function	NN	nsubj
and	CC	cc
use	NN	conj
be	VBP	conj
irrelevant	JJ	acomp
if	IN	mark
the	DT	det
product	NN	nsubj
be	VBZ	advcl
obvious	JJ	acomp
.	.	punct

This	DT	det
theory	NN	nsubj
be	VBZ	ccomp
flaw	VBN	acomp
,	,	punct
for	IN	prep
an	DT	det
unobvious	JJ	amod
improvement	NN	pobj
in	IN	prep
property	NNS	pobj
or	CC	cc
use	NN	conj
be	VBZ	ROOT
highly	RB	advmod
relevant	JJ	acomp
to	IN	prep
patentability	NN	pobj
of	IN	prep
a	DT	det
new	JJ	amod
product	NN	pobj
.	.	punct

 	_SP	

claim	NNS	nsubjpass
1	CD	nummod
and	CC	cc
6	CD	conj
be	VBD	auxpass
deem	VBN	ROOT
representative	NN	oprd
:	:	punct

 	_SP	

1	CD	ROOT
.	.	punct

a	DT	det
tablet	NN	compound
composition	NN	ROOT
suitable	JJ	amod
for	IN	prep
sublingual	JJ	amod
administration	NN	nsubj
comprising	NN	pobj
:	:	punct

 	_SP	

microparticle	NNS	ROOT
of	IN	prep
a	DT	det
pharmacologically	RB	advmod
-	HYPH	punct
effective	JJ	amod
amount	NN	pobj
of	IN	prep
buprenorphine	NN	pobj
,	,	punct
or	CC	cc
a	DT	det
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
salt	NN	conj
thereof	RB	advmod
,	,	punct
present	VBN	acl
upon	IN	prep
the	DT	det
surface	NN	pobj
of	IN	prep
carrier	NN	compound
particle	NNS	pobj
,	,	punct

 	_SP	

wherein	WRB	amod
microparticle	NNS	nsubj
of	IN	prep
buprenorphine	NN	pobj
or	CC	cc
a	DT	det
pharmaceutically	RB	advmod
acceptable	JJ	amod
salt	NN	conj
thereof	RB	advmod
be	VBP	ROOT
in	IN	prep
contact	NN	pobj
with	IN	prep
particle	NNS	pobj
comprise	VBG	acl
citric	JJ	amod
acid	NN	dobj
,	,	punct

 	_SP	

wherein	WRB	advmod
the	DT	det
buprenorphine	NN	nsubj
or	CC	cc
pharmaceutically	RB	advmod
acceptable	JJ	conj
salt	NN	conj
thereof	RB	advmod
and	CC	cc
the	DT	det
citric	JJ	amod
acid	NN	conj
be	VBP	ROOT
not	RB	neg
in	IN	prep
the	DT	det
same	JJ	amod
particle	NN	pobj
;	:	punct

 	_SP	

a	DT	det
pharmacologically	RB	advmod
-	HYPH	punct
effective	JJ	amod
amount	NN	ROOT
of	IN	prep
naloxone	NN	pobj
,	,	punct
or	CC	cc
a	DT	det
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
salt	NN	conj
thereof	RB	advmod
;	:	punct

 	_SP	

and	CC	cc
a	DT	det
disintegrant	NN	amod
select	VBN	acl
from	IN	prep
the	DT	det
group	NN	pobj
consist	VBG	acl
of	IN	prep
croscarmellose	JJ	compound
sodium	NN	pobj
,	,	punct
sodium	NN	compound
starch	NN	compound
glycolate	NN	conj
,	,	punct
crosslinke	VBD	amod
polyvinylpyrrolidone	NN	ROOT
and	CC	cc
mixture	NNS	conj
thereof	RB	advmod
.	.	punct

 	_SP	

6	CD	ROOT
.	.	punct

the	DT	det
composition	NN	nsubjpass
as	IN	mark
claim	VBN	advcl
in	IN	prep
claim	NN	pobj
1	CD	nummod
,	,	punct
wherein	WRB	advmod
the	DT	det
particle	NNS	nsubjpass
of	IN	prep
citric	JJ	amod
acid	NN	pobj
be	VBP	auxpass
present	VBN	ROOT
and	CC	cc
act	VB	conj
as	IN	prep
carrier	NN	compound
particle	NNS	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
all	PDT	predet
the	DT	det
ingredient	NNS	nsubjpass
in	IN	prep
the	DT	det
claim	NNS	pobj
be	VBD	auxpass
generally	RB	advmod
know	VBN	ccomp
,	,	punct
and	CC	cc
hold	VBD	conj
that	IN	mark
although	IN	mark
the	DT	det
specific	JJ	amod
formulation	NN	nsubjpass
be	VBD	auxpass
not	RB	neg
show	VBN	advcl
or	CC	cc
suggest	VBN	conj
in	IN	prep
any	DT	det
reference	NN	pobj
,	,	punct
the	DT	det
new	JJ	amod
combination	NN	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
to	IN	prep
a	DT	det
person	NN	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
.	.	punct

however	RB	advmod
,	,	punct
the	DT	det
prior	JJ	amod
art	NN	nsubj
do	VBZ	aux
not	RB	neg
show	VB	ROOT
or	CC	cc
suggest	VB	conj
the	DT	det
claim	VBN	amod
combination	NN	dobj
,	,	punct
and	CC	cc
do	VBZ	aux
not	RB	neg
show	VB	conj
or	CC	cc
suggest	VB	conj
that	IN	mark
this	DT	det
combination	NN	nsubj
would	MD	aux
achieve	VB	ccomp
enhance	VBN	amod
therapeutic	JJ	amod
effect	NN	dobj
while	IN	mark
be	VBG	advcl
less	RBR	advmod
subject	JJ	acomp
to	IN	prep
abuse	NN	pobj
.	.	punct

 	_SP	

the	DT	det
Prior	NNP	compound
Art	NNP	ROOT

 	_SP	

1	CD	meta
.	.	punct
suboxone	CD	ROOT
(r)	SYM	dobj
and	CC	cc
Subutex	NNP	conj
(r)	SYM	cc

 	_SP	

the	DT	det
buprenorphine	NN	nsubjpass
and	CC	cc
naloxone	JJ	conj
combination	NN	conj
in	IN	prep
the	DT	det
4:1	CD	nummod
ratio	NN	pobj
have	VBZ	aux
be	VBN	auxpass
use	VBN	ROOT
for	IN	prep
substitution	NN	compound
therapy	NN	pobj
at	IN	advmod
least	JJS	advmod
since	IN	prep
2002	CD	pobj
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	nsubj
Suboxone	NNP	nmod
sublingual	JJ	amod
tablet	NNS	nsubj
be	VBP	ROOT
a	DT	det
homogeneous	JJ	amod
combination	NN	attr
make	VBN	acl
by	IN	agent
mix	VBG	pcomp
the	DT	det
ingredient	NNS	dobj
of	IN	prep
buprenorphine	NN	pobj
,	,	punct
naloxone	NN	conj
,	,	punct
citric	JJ	amod
acid	NN	conj
,	,	punct
sodium	NN	compound
citrate	NN	conj
,	,	punct
and	CC	cc
sublingual	JJ	amod
excipient	NNS	conj
.	.	punct

dist	JJ	ROOT
.	.	punct

ct	UH	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	prep
769	CD	pobj
n.17	NN	conj
(	-LRB-	punct
cite	VBG	pcomp
Physicians	NNPS	poss
'	POS	case
Desk	NNP	compound
Reference	NNP	dobj
,	,	punct
58th	JJ	amod
ed	NN	appos
.	.	punct
2004	CD	pobj
)	-RRB-	punct
.	.	punct
subutex	NN	cc
(r)	SYM	nsubj
be	VBZ	ROOT
the	DT	det
same	JJ	amod
formulation	NN	attr
as	IN	prep
Suboxone	NNP	pobj
,	,	punct
but	CC	cc
without	IN	conj
the	DT	det
naloxone	NN	pobj
.	.	punct

WO2008/152347	NNP	ROOT

(	-LRB-	punct
"	``	punct
cairn	NNS	nsubj
"	''	punct
)	-RRB-	punct
,	,	punct
cite	VBN	acl
by	IN	agent
the	DT	det
examiner	NN	pobj
during	IN	prep
prosecution	NN	pobj
,	,	punct
describe	VBZ	ROOT
the	DT	det
tablet	NN	compound
formulation	NN	dobj
as	IN	prep
a	DT	det
wet	JJ	amod
granulation	NN	compound
process	NN	pobj
where	WRB	advmod
buprenorphine	NN	nsubj
,	,	punct
citric	JJ	amod
acid	NN	conj
,	,	punct
and	CC	cc
sodium	NN	compound
citrate	NN	conj
be	VBP	auxpass
dissolve	VBN	relcl
together	RB	advmod
and	CC	cc
then	RB	advmod
mix	VBN	conj
with	IN	prep
excipient	NNS	pobj
.	.	punct

see	VB	ROOT
Orexo	NNP	compound
Br	NNP	dobj
.	.	punct

at	IN	ROOT
14	CD	pobj
&	CC	cc
n.2	NNP	conj

(	-LRB-	punct
"	``	punct
cairn	NNS	nsubj
provide	VBZ	ROOT
the	DT	det
manufacturing	NN	compound
process	NN	dobj
for	IN	prep
Subutex	NNP	pobj
(r)	SYM	det
tablet	NNS	dobj
,	,	punct
a	DT	det
product	NN	appos
with	IN	prep
essentially	RB	advmod
the	DT	det
same	JJ	amod
formulation	NN	pobj
as	IN	prep
Suboxone	NNP	compound
(r)	SYM	nsubj
tablet	NNS	pobj
,	,	punct
but	CC	cc
without	IN	conj
naloxone	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

 	_SP	

Orexo	NNP	nsubj
attribute	VBZ	ROOT
the	DT	det
improvement	NNS	dobj
achieve	VBN	acl
by	IN	agent
the	DT	det
Zubsolv	NNP	compound
product	NN	pobj
to	IN	prep
the	DT	det
microparticle	NNS	pobj
of	IN	prep
buprenorphine	NN	pobj
adhere	VBN	acl
to	IN	prep
the	DT	det
surface	NN	pobj
of	IN	prep
citric	JJ	amod
acid	NN	compound
carrier	NN	compound
particle	NNS	pobj
.	.	punct

Orexo	NNP	nsubj
state	VBZ	ROOT
that	IN	mark
the	DT	det
66	CD	nummod
%	NN	npadvmod
high	JJR	amod
bioavailability	NN	nsubjpass
be	VBZ	auxpass
not	RB	neg
suggest	VBN	ccomp
or	CC	cc
reasonably	RB	advmod
predictable	JJ	conj
from	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

-PRON-	PRP	nsubjpass
have	VBP	aux
be	VBN	auxpass
direct	VBN	ROOT
to	IN	prep
no	DT	det
reference	NN	pobj
to	TO	aux
show	VB	advcl
or	CC	cc
suggest	VB	conj
otherwise	RB	advmod
.	.	punct

Orexo	NNP	nsubj
stress	VBZ	ROOT
the	DT	det
Examiner	NNP	poss
's	POS	case
statement	NN	dobj
in	IN	prep
allow	VBG	pcomp
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	dobj
,	,	punct
that	IN	mark
the	DT	det
improvement	NN	nsubj
be	VBZ	ccomp
due	JJ	acomp
to	IN	prep
the	DT	det
ingredient	NNS	pobj
and	CC	cc
the	DT	det
structure	NN	conj
:	:	punct

 	_SP	

the	DT	det
mere	JJ	amod
presence	NN	nsubj
of	IN	prep
citric	JJ	amod
acid	NN	pobj
in	IN	prep
the	DT	det
sublingual	JJ	amod
tablet	NNS	pobj
formulate	VBN	csubj
accord	VBG	prep
to	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
(	-LRB-	punct
e.g.	JJ	amod
Cairns	NNP	appos
)	-RRB-	punct
be	VBZ	ROOT
insufficient	JJ	acomp
to	TO	aux
achieve	VB	xcomp
the	DT	det
superior	JJ	amod
pharmacokinetic	JJ	amod
profile	NN	dobj
exhibit	VBN	acl
by	IN	agent
the	DT	det
instant	JJ	amod
invention	NN	pobj
.	.	punct

Applicant	NNP	nsubj
have	VBZ	aux
persuasively	RB	advmod
demonstrate	VBN	ROOT
that	IN	mark
the	DT	det
instant	JJ	amod
tablet	NN	nsubj
exhibit	VBZ	ccomp
unexpectedly	RB	advmod
superior	JJ	amod
sublingual	JJ	amod
buprenorphine	NN	compound
bioavailability	NN	dobj
due	IN	prep
to	IN	pcomp
the	DT	det
ingredient	NNS	pobj
as	RB	advmod
well	RB	advmod
as	IN	cc
the	DT	det
structural	JJ	amod
characteristic	NNS	conj
recite	VBN	acl
in	IN	prep
the	DT	det
instant	JJ	amod
claim	NNS	pobj
.	.	punct

 	_SP	

Notice	NNP	nsubj
of	IN	prep
Allowability	NNP	pobj
at	IN	prep
5	CD	pobj
(	-LRB-	punct
emphasis	NN	nsubj
original	JJ	amod
)	-RRB-	punct
,	,	punct
Application	NNP	compound
No.	SYM	compound
14/127,470	CD	appos
(	-LRB-	punct
issue	VBN	acl
as	IN	prep
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	pobj
)	-RRB-	punct
(	-LRB-	punct
November	NNP	npadvmod
4	CD	nummod
,	,	punct
2014	CD	nummod
)	-RRB-	punct
;	:	punct
see	VB	ROOT
also	RB	advmod
Orexo	NNP	compound
Br	NNP	dobj
.	.	punct

at	IN	ROOT
29	CD	pobj
(	-LRB-	punct
quote	VBG	pcomp
Notice	NNP	dobj
of	IN	prep
Allowability	NNP	pobj
at	IN	prep
5	CD	pobj
)	-RRB-	punct
.	.	punct

 	_SP	

2	CD	meta
.	.	punct
Suboxone	NNP	ROOT
(r)	SYM	dep
Film	NNP	attr

 	_SP	

U.S.	NNP	compound
patent	NN	compound
No.	SYM	nsubj
8,475,832	CD	nummod
(	-LRB-	punct
"	``	punct
the	DT	det
'	``	punct
832	CD	nummod
patent	NN	appos
"	''	punct
)	-RRB-	punct
describe	VBZ	ROOT
an	DT	det
orally	RB	advmod
dissolvable	JJ	amod
film	NN	dobj
that	WDT	nsubjpass
can	MD	aux
not	RB	neg
be	VB	auxpass
easily	RB	advmod
remove	VBN	relcl
once	RB	advmod
place	VBN	advcl
inside	IN	prep
the	DT	det
mouth	NN	pobj
.	.	punct

the	DT	det
film	NN	nsubj
contain	VBZ	ROOT
the	DT	det
buprenorphine	NN	nmod
/	SYM	punct
naloxone	JJ	appos
combination	NN	dobj
in	IN	prep
the	DT	det
4:1	CD	nummod
ratio	NN	pobj
,	,	punct
and	CC	cc
be	VBZ	auxpass
describe	VBN	conj
as	RB	prep
bioequivalent	JJ	amod
to	IN	prep
Suboxone	NNP	nmod
sublingual	JJ	amod
tablet	NNS	pobj
.	.	punct

the	DT	det
'	``	punct
832	CD	nummod
patent	NN	nsubj
teach	VBZ	ccomp
that	IN	det
optimum	JJ	amod
bioavailability	NN	nsubjpass
of	IN	prep
buprenorphine	NN	pobj
and	CC	cc
naloxone	NN	conj
from	IN	prep
the	DT	det
film	NN	pobj
be	VBZ	auxpass
achieve	VBN	ccomp
at	IN	prep
pH	NNS	pobj
3	CD	nummod
-	SYM	punct
3.5	CD	prep
,	,	punct
with	IN	mark
citric	JJ	amod
acid	NN	nsubj
include	VBN	advcl
in	IN	prep
the	DT	det
film	NN	pobj
to	TO	aux
lower	VB	advcl
the	DT	dobj
pH.	NNS	punct
the	DT	det
district	NN	compound
court	NN	nsubj
rely	VBD	ROOT
on	IN	prep
this	DT	det
presence	NN	pobj
of	IN	prep
citric	JJ	amod
acid	NN	pobj
to	TO	aux
render	VB	advcl
obvious	JJ	amod
the	DT	det
citric	JJ	amod
acid	NN	compound
carrier	NN	compound
particle	NNS	dobj
in	IN	prep
the	DT	det
Zubsolv	NNP	compound
formulation	NN	pobj
.	.	punct

 	_SP	

however	RB	advmod
,	,	punct
the	DT	det
'	``	punct
832	CD	nummod
patent	NN	nsubj
do	VBZ	aux
not	RB	neg
reduce	VB	ROOT
the	DT	det
amount	NN	dobj
of	IN	prep
buprenorphine	NN	pobj
need	VBN	acl
to	TO	aux
provide	VB	advcl
an	DT	det
effective	JJ	amod
substitution	NN	compound
therapy	NN	compound
dose	NN	dobj
.	.	punct

and	CC	cc
the	DT	det
use	NN	nsubj
of	IN	prep
film	NN	pobj
in	IN	prep
substitution	NN	compound
therapy	NN	compound
present	NNS	pobj
recognize	VBN	ROOT
problem	NNS	dobj
,	,	punct
as	IN	mark
state	VBN	advcl
in	IN	prep
the	DT	det
'	JJ	punct
330	CD	nummod
patent	NN	pobj
,	,	punct
for	IN	prep
the	DT	det
film	NN	pobj
do	VBZ	aux
not	RB	neg
dissolve	VB	conj
quickly	RB	advmod
and	CC	cc
a	DT	det
maximum	NN	nsubjpass
of	IN	prep
only	RB	advmod
two	CD	nummod
film	NNS	pobj
may	MD	aux
be	VB	auxpass
administer	VBN	conj
simultaneously	RB	advmod
,	,	punct
produce	VBG	advcl
inadequate	JJ	amod
dosage	NN	dobj
as	RB	advmod
well	RB	advmod
as	IN	cc
problem	NNS	conj
of	IN	prep
compliance	NN	pobj
and	CC	cc
administration	NN	conj
.	.	punct
'	''	punct
330	CD	nummod
patent	NN	oprd
,	,	punct
col.	NN	conj
2	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

43	CD	nummod
-	SYM	punct
50	CD	ROOT
.	.	punct

 	_SP	

3	CD	ROOT
.	.	punct

the	DT	det
Orexo	NNP	compound
Application	NNP	ROOT

 	_SP	

Orexo	NNP	poss
's	POS	case
U.S.	NNP	compound
Patent	NNP	compound
Application	NNP	compound
No.	SYM	ROOT

2010/0129443	CD	punct
(	-LRB-	punct
"	``	punct
the	DT	det
'	``	punct
443	CD	nummod
Application	NNP	nsubjpass
"	''	punct
)	-RRB-	punct
,	,	punct
title	VBN	acl
"	``	punct
Non	NNP	subtok
-	JJ	subtok
abusable	JJ	compound
Pharmaceutical	NNP	compound
Composition	NNP	compound
Comprising	NNP	compound
Opioids	NNPS	oprd
,	,	punct
"	''	punct
be	VBD	auxpass
file	VBN	ROOT
on	IN	prep
December	NNP	pobj
3	CD	nummod
,	,	punct
2007	CD	nummod
,	,	punct
publish	VBN	acl
on	IN	prep
May	NNP	pobj
27	CD	nummod
,	,	punct
2010	CD	nummod
,	,	punct
and	CC	cc
issue	VBN	conj
as	IN	prep
U.S.	NNP	compound
Patent	NNP	compound
No.	SYM	compound
8,470,361	CD	pobj
on	IN	prep
June	NNP	pobj
25	CD	nummod
,	,	punct
2013	CD	nummod
.	.	punct

-PRON-	PRP	nsubj
be	VBZ	ROOT
prior	JJ	amod
art	NN	attr
as	IN	prep
of	IN	prep
-PRON-	PRP$	poss
filing	NN	compound
date	NN	pobj
.	.	punct

 	_SP	

the	DT	det
'	``	punct
443	CD	nummod
Application	NNP	nsubj
describe	VBZ	ROOT
sublingual	JJ	amod
tablet	NNS	dobj
where	WRB	advmod
small	JJR	amod
particle	NNS	nsubjpass
of	IN	prep
opioid	NN	amod
agonist	NNS	pobj
be	VBP	auxpass
carry	VBN	relcl
on	IN	prep
large	JJR	amod
particle	NNS	pobj
that	WDT	nsubj
include	VBP	relcl
an	DT	det
opioid	JJ	amod
antagonist	NN	dobj
.	.	punct

the	DT	det
'	``	punct
443	CD	nummod
Application	NNP	nsubj
list	VBZ	ROOT
many	JJ	amod
opioid	NN	amod
agonist	NNS	dobj
include	VBG	prep
buprenorphine	NN	pobj
,	,	punct
and	CC	cc
many	JJ	amod
antagonist	NNS	conj
include	VBG	prep
naloxone	RB	pobj
.	.	punct

however	RB	advmod
,	,	punct
citric	JJ	amod
acid	NN	nsubjpass
be	VBZ	auxpass
not	RB	neg
mention	VBN	ROOT
or	CC	cc
suggest	VBN	conj
as	IN	prep
the	DT	det
carrier	NN	compound
particle	NN	pobj
.	.	punct

 	_SP	

4	CD	ROOT
.	.	punct

European	NNP	amod
Patent	NNP	compound
Application	NNP	compound
No.	SYM	compound
EP	NNP	ROOT
0324725	CD	nummod

 	_SP	

European	NNP	compound
Patent	NNP	compound
Application	NNP	compound
No.	SYM	compound
EP	NNP	ROOT
0324725	CD	appos

(	-LRB-	punct
"	``	punct
the	DT	det
EP	NNP	poss
'	POS	case
725	CD	nummod
Application	NNP	nsubj
"	''	punct
)	-RRB-	punct
list	VBZ	ROOT
a	DT	det
large	JJ	amod
number	NN	dobj
of	IN	prep
watersoluble	JJ	amod
carrier	NN	compound
particle	NNS	pobj
,	,	punct
to	TO	prep
which	WDT	pobj
small	JJR	amod
particle	NNS	nsubjpass
of	IN	prep
a	DT	det
pharmaceutically	RB	advmod
active	JJ	amod
substance	NN	pobj
may	MD	aux
be	VB	auxpass
adhere	VBN	relcl
.	.	punct

the	DT	det
EP	NNP	poss
'	POS	case
725	CD	nummod
Application	NNP	nsubj
do	VBZ	aux
not	RB	neg
mention	VB	ccomp
sublingual	JJ	amod
tablet	NNS	dobj
,	,	punct
do	VBZ	aux
not	RB	neg
mention	VB	ROOT
opioid	NNS	dobj
as	IN	prep
the	DT	det
active	JJ	amod
substance	NN	pobj
,	,	punct
and	CC	cc
do	VBZ	aux
not	RB	neg
mention	VB	conj
citric	JJ	amod
acid	NN	dobj
as	IN	prep
a	DT	det
carrier	NN	pobj
.	.	punct

 	_SP	

the	DT	det
District	NNP	compound
Court	NNP	compound
Decision	NNP	ROOT

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
hold	VBD	ROOT
the	DT	det
assert	VBN	amod
'	POS	punct
330	CD	nummod
patent	NN	compound
claim	VBZ	dobj
invalid	JJ	oprd
,	,	punct
rule	VBG	advcl
that	IN	mark
a	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
obviously	RB	advmod
have	VB	aux
select	VBN	ccomp
these	DT	det
component	NNS	dobj
from	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
and	CC	cc
reformulate	VBD	conj
-PRON-	PRP	dobj
as	IN	prep
in	IN	prep
the	DT	det
'	JJ	punct
330	CD	nummod
patent	NN	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	ROOT
that	IN	mark
the	DT	det
'	``	punct
443	CD	nummod
Application	NNP	nsubj
teach	VBD	ccomp
that	IN	mark
"	``	punct
a	DT	det
person	NN	nsubjpass
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	auxpass
motivate	VBN	ccomp
to	TO	aux
reformulate	VB	xcomp
Suboxone	NNP	compound
tablet	NNS	dobj
as	IN	prep
an	DT	det
interactive	JJ	amod
mixture	NN	pobj
to	TO	aux
improve	VB	relcl
bioavailability	NN	dobj
,	,	punct
"	``	punct
dist	JJ	npadvmod
.	.	punct

ct	UH	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	prep
773	CD	pobj
;	:	punct
that	IN	mark
the	DT	det
'	``	punct
832	CD	nummod
patent	NN	nsubj
for	IN	prep
an	DT	det
oral	JJ	amod
film	NN	pobj
"	''	punct
expressly	RB	advmod
teach	VBD	ROOT
a	DT	det
person	NN	dobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
that	WDT	mark
the	DT	det
addition	NN	nsubj
of	IN	prep
citric	JJ	amod
acid	NN	pobj
facilitate	VBD	ccomp
an	DT	det
increase	VBN	amod
level	NN	dobj
of	IN	prep
absorption	NN	pobj
of	IN	prep
buprenorphine	NN	pobj
despite	IN	prep
a	DT	det
low	JJR	amod
pH	NNS	pobj
,	,	punct
"	``	punct
-PRON-	PRP	subtok
would	MD	subtok
.	.	punct

at	IN	ROOT
772	CD	pobj
-	SYM	punct
73	CD	prep
;	:	punct
and	CC	cc
that	IN	mark
the	DT	det
EP	NNP	poss
'	POS	case
725	CD	nummod
Application	NNP	nsubj
"	''	punct
describe	VBD	conj
how	WRB	advmod
to	TO	aux
make	VB	xcomp
such	PDT	predet
a	DT	det
mixture	NN	nsubj
use	VBG	ccomp
dry	JJ	amod
mixing	NN	dobj
,	,	punct
"	``	punct
-PRON-	PRP	subtok
would	MD	subtok
.	.	punct
at	IN	prep
773	CD	pobj
.	.	punct

 	_SP	

In	IN	prep
response	NN	pobj
to	IN	prep
Orexo	NNP	poss
's	POS	case
argument	NN	pobj
that	IN	mark
no	DT	det
reference	NN	nsubj
show	VBD	ccomp
the	DT	det
new	JJ	amod
formulation	NN	dobj
in	IN	prep
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	pobj
,	,	punct
stress	VBG	advcl
the	DT	det
unexpectedly	RB	advmod
enhance	VBN	amod
bioavailability	NN	dobj
and	CC	cc
-PRON-	PRP$	poss
benefit	NNS	conj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
reason	VBD	ROOT
that	IN	mark
a	DT	det
skilled	JJ	amod
artisan	NN	nsubj
"	''	punct
would	MD	aux
not	RB	neg
have	VB	aux
exclude	VBN	ccomp
citric	JJ	amod
acid	NN	dobj
"	''	punct
as	IN	prep
a	DT	det
carrier	NN	pobj
and	CC	cc
"	''	punct
would	MD	aux
have	VB	aux
know	VBN	conj
how	WRB	advmod
to	TO	aux
form	VB	xcomp
an	DT	det
interactive	JJ	amod
mixture	NN	dobj
use	VBG	acl
citric	JJ	amod
acid	NN	dobj
"	''	punct
.	.	punct

Idaho	NNP	ROOT

the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
the	DT	det
'	``	punct
832	CD	nummod
patent	NN	nsubj
teach	VBD	ccomp
"	``	punct
the	DT	det
use	NN	nsubj
of	IN	prep
citric	JJ	amod
acid	NN	pobj
with	IN	prep
an	DT	det
interactive	JJ	amod
mixture	NN	pobj
would	MD	aux
also	RB	advmod
improve	VB	ccomp
[	-LRB-	punct
buprenorphine	NN	nmod
]	-RRB-	punct
bioavailability	NN	dobj
,	,	punct
"	``	punct
-PRON-	PRP	ccomp
would	MD	subtok
.	.	punct
,	,	punct
and	CC	cc
conclude	VBD	conj
that	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
to	TO	aux
use	VB	xcomp
citric	JJ	amod
acid	NN	dobj
as	IN	prep
carrier	NN	compound
particle	NNS	pobj
.	.	punct

 	_SP	

Orexo	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
a	DT	det
person	NN	nsubjpass
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	auxpass
dissuade	VBN	ccomp
from	IN	prep
use	VBG	pcomp
citric	JJ	amod
acid	NN	dobj
in	IN	prep
this	DT	det
interactive	JJ	amod
mixture	NN	pobj
because	IN	mark
Examples	NNP	nsubj
6	CD	nummod
-	SYM	punct
8	CD	prep
of	IN	prep
the	DT	det
'	``	punct
832	CD	nummod
patent	NN	pobj
teach	VBD	advcl
that	IN	mark
as	IN	mark
the	DT	det
pH	NNS	nsubjpass
be	VBZ	auxpass
lower	VBN	advcl
through	IN	prep
use	NN	pobj
of	IN	prep
citric	JJ	amod
acid	NN	pobj
,	,	punct
the	DT	det
buprenorphine	JJ	compound
bioavailability	NN	compound
increase	NN	nsubjpass
be	VBZ	auxpass
accompany	VBN	ccomp
by	IN	agent
a	DT	det
compromise	VBN	amod
naloxone	NN	amod
availability	NN	pobj
such	JJ	amod
that	IN	mark
the	DT	det
4:1	CD	nummod
ratio	NN	nsubjpass
be	VBZ	auxpass
lose	VBN	acl
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
describe	VBD	ccomp
this	DT	det
argument	NN	dobj
as	IN	prep
irrelevant	JJ	amod
because	IN	mark
the	DT	det
4:1	CD	nummod
ratio	NN	nsubj
be	VBZ	advcl
an	DT	det
"	``	punct
unclaimed	JJ	amod
feature	NN	attr
"	''	punct
of	IN	prep
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	pobj
,	,	punct
the	DT	det
court	NN	nsubj
state	VBG	acl
"	``	punct
any	DT	det
problem	NNS	dobj
with	IN	prep
maintain	VBG	pcomp
the	DT	det
ratio	NN	compound
forecast	NN	dobj
by	IN	prep
the	DT	det
'	``	punct
832	CD	nummod
patent	NN	pobj
go	VBZ	ccomp
to	IN	prep
the	DT	det
reasonable	JJ	amod
expectation	NN	pobj
of	IN	prep
success	NN	compound
requirement	NN	pobj
,	,	punct
not	RB	neg
to	IN	prep
motivation	NN	pobj
to	TO	aux
combine	VB	relcl
;	:	punct
i.e.	FW	advmod
,	,	punct
this	DT	det
argument	NN	nsubj
be	VBZ	ROOT
irrelevant	JJ	acomp
in	IN	prep
this	DT	det
context	NN	pobj
"	''	punct
.	.	punct

Idaho	NNS	ROOT
at	IN	prep
773	CD	nummod
n.23	JJ	pobj
.	.	punct

 	_SP	

Orexo	NNP	nsubj
stress	VBZ	ROOT
that	IN	mark
no	DT	det
reference	NN	nsubj
teach	VBZ	ccomp
or	CC	cc
suggest	VBZ	conj
use	VBG	xcomp
citric	JJ	amod
acid	NN	compound
particle	NNS	dobj
as	IN	prep
a	DT	det
carrier	NN	pobj
for	IN	prep
micronized	JJ	amod
buprenorphine	NN	pobj
,	,	punct
and	CC	cc
that	IN	mark
the	DT	det
benefit	NNS	nsubj
of	IN	prep
this	DT	det
formulation	NN	pobj
be	VBD	conj
unexpected	JJ	acomp
.	.	punct

reject	VBG	advcl
this	DT	det
argument	NN	dobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
cite	VBD	ROOT
the	DT	det
testimony	NN	dobj
of	IN	prep
Actavis	NNP	poss
'	POS	case
expert	NN	pobj
that	IN	mark
citric	JJ	amod
acid	NN	nsubj
"	''	punct
fit	VBZ	relcl
the	DT	det
definition	NN	dobj
of	IN	prep
a	DT	det
carrier	NN	compound
particle	NN	pobj
"	''	punct
and	CC	cc
"	``	punct
therefore	RB	advmod
-PRON-	PRP	nsubj
would	MD	aux
act	VB	conj
as	IN	prep
a	DT	det
carrier	NN	compound
particle	NN	pobj
,	,	punct
because	IN	mark
-PRON-	PRP	nsubj
be	VBZ	advcl
in	IN	prep
the	DT	det
Suboxone	NNP	compound
tablet	NN	pobj
"	''	punct
.	.	punct

dist	JJ	ROOT
.	.	punct

ct	UH	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	ROOT
771	CD	pobj
(	-LRB-	punct
quote	VBG	pobj
testimony	NN	dobj
of	IN	prep
Dr.	NNP	compound
Dyar	NNP	pobj
)	-RRB-	punct
.	.	punct

however	RB	advmod
,	,	punct
no	DT	det
reference	NN	nsubj
suggest	VBZ	ROOT
citric	JJ	amod
acid	NN	compound
carrier	NN	compound
particle	NNS	dobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
also	RB	advmod
discuss	VBD	ROOT
the	DT	det
objective	JJ	amod
indicia	NN	dobj
of	IN	prep
unobviousness	NN	pobj
,	,	punct
respond	VBG	advcl
to	IN	prep
Orexo	NNP	poss
's	POS	case
argument	NNS	pobj
of	IN	prep
unexpectedly	RB	advmod
increase	VBN	amod
bioavailability	NN	pobj
,	,	punct
long	RB	advmod
-	HYPH	punct
feel	VBN	amod
need	NN	dobj
for	IN	prep
improved	JJ	amod
treatment	NN	pobj
of	IN	prep
opioid	NN	amod
dependence	NN	pobj
,	,	punct
copying	NN	acl
by	IN	prep
Actavis	NNP	pobj
,	,	punct
and	CC	cc
hindsight	NN	conj
.	.	punct

the	DT	det
court	NN	nsubj
state	VBD	ROOT
that	IN	mark
"	``	punct
the	DT	det
unexpected	JJ	amod
result	NN	nsubj
of	IN	prep
increase	VBN	amod
bioavailability	NN	pobj
provide	VBZ	ccomp
some	DT	det
support	NN	dobj
for	IN	prep
nonobviousness	NN	pobj
,	,	punct
"	``	punct
dist	JJ	npadvmod
.	.	punct

ct	UH	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	ROOT
776	CD	pobj
,	,	punct
but	CC	cc
find	VBD	conj
that	IN	mark
interactive	JJ	amod
mixture	NNS	nsubjpass
be	VBD	auxpass
generally	RB	advmod
know	VBN	ccomp
to	TO	aux
improve	VB	xcomp
bioavailability	NN	dobj
and	CC	cc
that	IN	mark
the	DT	det
increase	NN	nsubj
here	RB	advmod
be	VBD	conj
a	DT	det
"	``	punct
'	``	punct
difference	NN	attr
in	IN	prep
degree	NN	pobj
,	,	punct
'	''	punct
not	RB	neg
a	DT	det
difference	NN	appos
in	IN	prep
'	``	punct
kind	NN	pobj
.	.	punct
'	''	punct
"	``	punct
Idaho	NNS	pobj
at	IN	prep
774	CD	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	ROOT
that	IN	mark
Orexo	NNP	poss
's	POS	case
argument	NNS	nsubj
of	IN	prep
teach	VBG	pcomp
away	RB	advmod
,	,	punct
long	RB	advmod
-	HYPH	punct
feel	VBN	compound
need	NN	conj
,	,	punct
and	CC	cc
copying	NN	conj
be	VBD	ccomp
"	``	punct
not	RB	neg
persuasive	JJ	amod
evidence	NN	attr
"	''	punct
.	.	punct

Idaho	NNS	ROOT
at	IN	prep
773	CD	nummod
n.27	NN	pobj
,	,	punct
776	CD	appos
.	.	punct

the	DT	det
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
"	``	punct
Actavis	NNP	nsubj
have	VBZ	aux
meet	VBN	ccomp
-PRON-	PRP$	poss
burden	NN	dobj
to	TO	aux
prove	VB	acl
,	,	punct
by	IN	prep
clear	JJ	pobj
and	CC	cc
convincing	JJ	conj
evidence	NN	dobj
,	,	punct
that	IN	nsubj
claim	VBZ	advcl
1	CD	dobj
,	,	punct
3	CD	npadvmod
-	SYM	punct
6	CD	prep
,	,	punct
and	CC	cc
8	CD	nsubj
-	SYM	punct
10	CD	prep
be	VBP	conj
obvious	JJ	acomp
"	''	punct
.	.	punct

Idaho	NNS	ROOT
at	IN	prep
776	CD	pobj
.	.	punct

 	_SP	

Standard	NNP	ROOT
of	IN	prep
Review	NNP	pobj

 	_SP	

follow	VBG	advcl
a	DT	det
bench	NN	compound
trial	NN	dobj
,	,	punct
-PRON-	PRP	nsubj
review	VBP	ROOT
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
factual	JJ	amod
finding	NNS	dobj
for	IN	prep
clear	JJ	amod
error	NN	pobj
.	.	punct

conclusion	NNS	nsubj
of	IN	prep
law	NN	pobj
receive	VBP	ROOT
de	FW	nmod
novo	NN	compound
determination	NN	dobj
.	.	punct

see	VB	ROOT

In	IN	ROOT
re	IN	pobj
Cyclobenzaprine	NNP	compound
Hydrochloride	NNP	compound
Extended	NNP	compound
-	HYPH	punct
Release	NNP	compound
Capsule	NNP	compound
Patent	NNP	compound
Litig	NNP	pobj
.	.	punct
,	,	punct
676	CD	nummod
f.3d	CD	appos
1063	CD	nummod
,	,	punct
1069	CD	npadvmod

(	-LRB-	punct
Fed	NNP	ROOT
.	.	punct
Cir	NNP	subtok
.	.	punct
2012	CD	nummod
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
While	IN	mark
-PRON-	PRP	nsubj
afford	VBP	advcl
deference	NN	dobj
to	IN	prep
a	DT	det
district	NN	compound
court	NN	poss
's	POS	case
factual	JJ	amod
finding	NNS	pobj
,	,	punct
however	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
retain	VBP	ccomp
plenary	JJ	amod
review	NN	dobj
to	TO	aux
determine	VB	xcomp
whether	IN	mark
,	,	punct
as	IN	prep
a	DT	det
legal	JJ	amod
matter	NN	pobj
,	,	punct
the	DT	det
evidence	NN	nsubj
satisfy	VBZ	ccomp
the	DT	det
clear	JJ	amod
-	HYPH	punct
and	CC	cc
-	HYPH	punct
convince	VBG	conj
standard	NN	dobj
of	IN	prep
proof	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

 	_SP	

Obviousness	NNP	nsubj
be	VBZ	ROOT
a	DT	det
question	NN	attr
of	IN	prep
law	NN	pobj
,	,	punct
base	VBN	acl
on	IN	prep
the	DT	det
fact	NNS	pobj
of	IN	prep
(	-LRB-	punct
1	LS	pobj
)	-RRB-	punct
the	DT	det
scope	NN	pobj
and	CC	cc
content	NN	conj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
(	-LRB-	punct
2	LS	appos
)	-RRB-	punct
the	DT	det
level	NN	conj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
field	NN	pobj
,	,	punct
(	-LRB-	punct
3	LS	meta
)	-RRB-	punct
the	DT	det
difference	NNS	appos
between	IN	prep
the	DT	det
claim	VBN	amod
invention	NN	pobj
and	CC	cc
the	DT	det
prior	JJ	amod
art	NN	conj
,	,	punct
and	CC	cc
(	-LRB-	punct
4	LS	nummod
)	-RRB-	punct
any	DT	det
objective	JJ	amod
indicia	NN	conj
of	IN	prep
nonobviousness	NN	pobj
.	.	punct

Graham	NNP	ROOT
v.	IN	prep
John	NNP	compound
Deere	NNP	compound
Co.	NNP	pobj
,	,	punct
383	CD	nummod
U.S.	NNP	conj
1	CD	nummod
,	,	punct
17	CD	npadvmod
-	SYM	punct
18	CD	prep
,	,	punct
86	CD	nummod
S.Ct	NNP	subtok
.	.	punct

684	CD	ROOT
,	,	punct
15	CD	nummod
l.ed.2d	NN	nmod
545	CD	nummod
(	-LRB-	punct
1966	CD	appos
)	-RRB-	punct
.	.	punct

to	TO	aux
invalidate	VB	advcl
a	DT	det
patent	NN	dobj
on	IN	prep
the	DT	det
ground	NN	pobj
of	IN	prep
obviousness	JJ	pobj
,	,	punct
the	DT	det
challenger	NN	nsubj
have	VBZ	ROOT
the	DT	det
burden	NN	dobj
of	IN	prep
prove	VBG	pcomp
that	IN	mark
the	DT	det
subject	JJ	amod
matter	NN	nsubj
as	IN	prep
a	DT	det
whole	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
to	IN	prep
a	DT	det
person	NN	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
field	NN	pobj
of	IN	prep
the	DT	det
invention	NN	pobj
.	.	punct

35	CD	ROOT
u.s.c.	NN	subtok
¡±	NNP	punct

103(a	CD	ROOT
)	-RRB-	punct
.	.	punct

a	DT	det
party	NN	nsubj
seek	VBG	acl
to	TO	aux
invalidate	VB	xcomp
a	DT	det
patent	NN	dobj
on	IN	prep
obviousness	JJ	amod
ground	NNS	pobj
must	MD	aux
demonstrate	VB	ROOT
by	IN	prep
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
that	IN	mark
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
would	MD	aux
have	VB	aux
select	VBN	ccomp
and	CC	cc
combine	VBN	conj
and	CC	cc
modify	VBD	conj
the	DT	det
subject	JJ	amod
matter	NN	dobj
of	IN	prep
the	DT	det
reference	NNS	pobj
in	IN	prep
the	DT	det
manner	NN	pobj
of	IN	prep
the	DT	det
claim	VBN	amod
invention	NN	pobj
,	,	punct
with	IN	prep
a	DT	det
reasonable	JJ	amod
expectation	NN	pobj
of	IN	prep
success	NN	pobj
.	.	punct

e.g.	RB	dep
,	,	punct
InTouch	NNP	compound
Techs	NNP	ROOT
.	NNP	punct
,	,	punct
Inc.	NNP	npadvmod
v.	IN	prep
VGO	NNP	nmod
Commc'ns	NNP	nmod
,	,	punct
Inc.	NNP	conj
,	,	punct
751	CD	nummod
f.3d	CD	appos
1327	CD	nummod
,	,	punct
1347	CD	npadvmod

(	-LRB-	punct
Fed	NNP	ROOT
.	.	punct
Cir	NNP	subtok
.	.	punct
2014	CD	nummod
)	-RRB-	punct
.	.	punct

 	_SP	

judicial	JJ	amod
hindsight	NN	nsubjpass
must	MD	aux
be	VB	auxpass
avoid	VBN	ROOT
.	.	punct

see	VB	ROOT

KSR	NNP	compound
Int'l	NNP	subtok
Co.	NNP	subtok
v.	CC	ROOT
Teleflex	NNP	compound
Inc.	NNP	pobj
,	,	punct
550	CD	nummod
U.S.	NNP	npadvmod
398	CD	nummod
,	,	punct
421	CD	nummod
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	npadvmod

1727	CD	ROOT
,	,	punct
167	CD	nummod
l.ed.2d	NN	appos
705	CD	nummod
(	-LRB-	punct
2007	CD	npadvmod
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
a	DT	det
factfinder	NN	nsubj
should	MD	aux
be	VB	parataxis
aware	JJ	acomp
,	,	punct
of	IN	prep
course	NN	pobj
,	,	punct
of	IN	prep
the	DT	det
distortion	NN	pobj
cause	VBN	acl
by	IN	agent
hindsight	NN	compound
bias	NN	pobj
and	CC	cc
must	MD	aux
be	VB	conj
cautious	JJ	acomp
of	IN	prep
argument	NNS	pobj
reliant	JJ	amod
upon	IN	prep
ex	FW	nmod
post	NN	npadvmod
reasoning	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct

.	.	ROOT

-PRON-	PRP	nsubj
be	VBZ	ROOT
inappropriate	JJ	acomp
to	TO	aux
use	VB	xcomp
the	DT	det
template	NN	dobj
provide	VBN	acl
by	IN	agent
the	DT	det
inventor	NN	pobj
,	,	punct
to	TO	aux
render	VB	xcomp
the	DT	det
inventor	NN	poss
's	POS	case
contribution	NN	nsubj
obvious	JJ	ccomp
.	.	punct

see	VB	ROOT
Interconnect	NNP	compound
Planning	NNP	compound
Corp.	NNP	dobj
v.	IN	prep
Feil	NNP	pobj
,	,	punct
774	CD	nummod
f.2d	CD	appos
1132	CD	npadvmod
,	,	punct
1138	CD	npadvmod

(	-LRB-	punct
Fed	NNP	ccomp
.	.	punct
Cir	NNP	subtok
.	.	punct
1985	CD	nummod
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
the	DT	det
invention	NN	nsubjpass
must	MD	aux
be	VB	auxpass
view	VBN	ROOT
not	RB	neg
with	IN	prep
the	DT	det
blueprint	NN	pobj
draw	VBN	acl
by	IN	agent
the	DT	det
inventor	NN	pobj
,	,	punct
but	CC	cc
in	IN	prep
the	DT	det
state	NN	pobj
of	IN	prep
the	DT	det
art	NN	pobj
that	WDT	nsubj
exist	VBD	relcl
at	IN	prep
the	DT	det
time	NN	pobj
.	.	punct
the	DT	det
invention	NN	nsubjpass
must	MD	aux
be	VB	auxpass
evaluate	VBN	advcl
not	RB	neg
through	IN	prep
the	DT	det
eye	NNS	pobj
of	IN	prep
the	DT	det
inventor	NN	pobj
,	,	punct
who	WP	nsubj
may	MD	aux
have	VB	aux
be	VBN	relcl
of	IN	prep
exceptional	JJ	amod
skill	NN	pobj
,	,	punct
but	CC	cc
as	IN	prep
by	IN	prep
one	CD	pobj
of	IN	prep
'	``	punct
ordinary	JJ	amod
skill	NN	pobj
'	''	punct
.	.	punct
"	''	punct
)	-RRB-	punct
.	.	punct

 	_SP	

Obviousness	NNP	ROOT

 	_SP	

In	IN	prep
hold	VBG	pcomp
the	DT	det
'	``	punct
330	CD	compound
patent	NN	poss
's	POS	case
claim	NNS	nsubj
invalid	JJ	oprd
for	IN	prep
obviousness	JJ	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
cite	VBD	ROOT
the	DT	det
'	``	punct
832	CD	nummod
patent	NN	dobj
to	TO	aux
show	VB	advcl
that	IN	mark
"	``	punct
the	DT	det
use	NN	nsubj
of	IN	prep
citric	JJ	amod
acid	NN	pobj
with	IN	prep
an	DT	det
interactive	JJ	amod
mixture	NN	pobj
would	MD	aux
also	RB	advmod
improve	VB	ccomp
bioavailability	NN	dobj
"	''	punct
.	.	punct

dist	JJ	ROOT
.	.	punct

ct	UH	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	ROOT
773	CD	pobj
.	.	punct

the	DT	det
'	``	punct
832	CD	nummod
patent	NN	nsubj
be	VBZ	ROOT
for	IN	prep
a	DT	det
film	NN	pobj
that	WDT	nsubj
include	VBZ	relcl
citric	JJ	amod
acid	NN	dobj
to	TO	aux
lower	VB	xcomp
the	DT	det
pH	NNS	dobj
of	IN	prep
the	DT	det
film	NN	pobj
.	.	punct

example	NN	nsubj
7	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
832	CD	nummod
patent	NN	pobj
show	VBZ	ROOT
that	IN	dobj
a	DT	det
lowering	NN	pobj
of	IN	prep
pH	NNS	pobj
to	IN	prep
5.5	CD	nummod
increase	NNS	pobj
buprenorphine	NN	compound
bioavailability	NN	dobj
,	,	punct
but	CC	cc
also	RB	advmod
compromise	VBZ	conj
the	DT	det
desire	VBN	amod
4:1	CD	nummod
ratio	NN	dobj
of	IN	prep
buprenorphine	NN	pobj
to	IN	prep
naloxone	NN	pobj
.	.	punct
'	''	punct

832	CD	nummod
patent	NN	ROOT
,	,	punct
col.	NN	conj
21	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

17	CD	ROOT
-	SYM	punct
26	CD	prep
.	.	punct

example	NN	nsubj
8	CD	nummod
of	IN	prep
the	DT	det
'	``	punct
832	CD	nummod
patent	NN	pobj
show	VBZ	ROOT
that	IN	mark
a	DT	det
further	JJ	amod
decrease	NN	nsubj
in	IN	prep
pH	NNS	pobj
to	IN	prep
3.5	CD	pobj
use	VBG	acl
citric	JJ	amod
acid	NN	dobj
maintain	VBD	ccomp
the	DT	det
4:1	CD	nummod
ratio	NN	dobj
but	CC	cc
do	VBD	aux
not	RB	neg
increase	VB	conj
buprenorphine	JJ	compound
bioavailability	NN	dobj
.	.	punct

Idaho	NNP	ROOT
,	,	punct
col.	NN	conj
23	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

1	CD	ROOT
-	SYM	punct
11	CD	prep
.	.	punct

the	DT	det
'	``	punct
832	CD	nummod
patent	NN	nsubjpass
be	VBZ	auxpass
direct	VBN	ROOT
to	IN	prep
replace	VBG	pcomp
sublingual	JJ	amod
tablet	NNS	dobj
with	IN	prep
oral	JJ	amod
film	NN	pobj
,	,	punct
for	IN	prep
possible	JJ	amod
advantage	NN	pobj
in	IN	prep
administration	NN	pobj
.	.	punct

there	EX	expl
be	VBZ	ROOT
no	DT	det
suggestion	NN	attr
of	IN	prep
the	DT	det
different	JJ	amod
structure	NN	pobj
of	IN	prep
the	DT	det
Zubsolv	NNP	compound
tablet	NN	pobj
and	CC	cc
-PRON-	PRP$	poss
advantage	NN	conj
in	IN	prep
deter	VBG	pcomp
abuse	NN	dobj
.	.	punct

the	DT	det
Zubsolv	NNP	compound
structure	NN	nsubjpass
be	VBZ	auxpass
achieve	VBN	ROOT
solely	RB	advmod
upon	IN	prep
the	DT	det
hindsight	NN	compound
knowledge	NN	pobj
of	IN	prep
the	DT	det
structure	NN	pobj
and	CC	cc
benefit	NNS	conj
describe	VBN	acl
in	IN	prep
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
cite	VBD	ROOT
the	DT	det
Orexo	NNP	poss
'	POS	case
443	CD	nummod
Application	NNP	dobj
for	IN	prep
-PRON-	PRP$	poss
disclosure	NN	pobj
of	IN	prep
particle	NNS	pobj
of	IN	prep
buprenorphine	NN	pobj
adhere	VBN	acl
to	IN	prep
carrier	NN	compound
particle	NNS	pobj
.	.	punct

however	RB	advmod
,	,	punct
the	DT	det
'	``	punct
443	CD	nummod
Application	NNP	nsubj
do	VBZ	aux
not	RB	neg
mention	VB	ROOT
citric	JJ	amod
acid	NN	dobj
in	IN	prep
-PRON-	PRP$	poss
extensive	JJ	amod
list	NN	pobj
of	IN	prep
carrier	NNS	pobj
,	,	punct
and	CC	cc
do	VBZ	aux
not	RB	neg
suggest	VB	conj
that	IN	mark
citric	JJ	amod
acid	NN	compound
carrier	NN	compound
particle	NNS	nsubj
may	MD	aux
provide	VB	ccomp
benefit	NNS	dobj
compare	VBN	prep
with	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

These	DT	det
benefit	NNS	nsubjpass
be	VBD	auxpass
not	RB	neg
predict	VBN	ROOT
or	CC	cc
suggest	VBN	conj
in	IN	prep
any	DT	det
reference	NN	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
cite	VBD	ROOT
the	DT	det
EP	NNP	poss
'	POS	case
725	CD	nummod
Application	NNP	dobj
for	IN	prep
-PRON-	PRP$	poss
general	JJ	amod
description	NN	pobj
of	IN	prep
interactive	JJ	amod
mixture	NNS	pobj
as	IN	prep
pharmaceutical	JJ	amod
formulation	NNS	pobj
.	.	punct

This	DT	det
reference	NN	nsubj
do	VBZ	aux
not	RB	neg
mention	VB	ROOT
opioid	NNS	dobj
,	,	punct
do	VBZ	aux
not	RB	neg
mention	VB	conj
sublingual	JJ	amod
tablet	NNS	dobj
,	,	punct
do	VBZ	aux
not	RB	neg
mention	VB	conj
citric	JJ	amod
acid	NN	dobj
in	IN	prep
-PRON-	PRP$	poss
extensive	JJ	amod
list	NN	pobj
of	IN	prep
carrier	NN	compound
particle	NNS	pobj
,	,	punct
and	CC	cc
do	VBZ	aux
not	RB	neg
suggest	VB	conj
the	DT	det
formulation	NN	dobj
in	IN	prep
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	pobj
or	CC	cc
-PRON-	PRP$	poss
unexpected	JJ	amod
benefit	NNS	conj
.	.	punct

 	_SP	

the	DT	det
product	NN	compound
herein	NN	nsubj
be	VBZ	ROOT
admittedly	RB	advmod
new	JJ	acomp
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
acknowledge	VBD	ROOT
the	DT	det
undisputed	JJ	amod
testimony	NN	dobj
of	IN	prep
Orexo	NNP	poss
's	POS	case
co	NN	subtok
-	NN	subtok
founder	NN	pobj
,	,	punct
Mr.	NNP	compound
Thomas	NNP	compound
Lundqvist	NNP	appos
,	,	punct
and	CC	cc
Orexo	NNP	poss
's	POS	case
global	JJ	amod
chief	JJ	amod
medical	JJ	amod
officer	NN	conj
,	,	punct
Dr.	NNP	compound
Michael	NNP	compound
Sumner	NNP	appos
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
write	VBD	ROOT
:	:	punct

 	_SP	

Lundqvist	NNP	nsubj
testify	VBD	ROOT
that	IN	mark
the	DT	det
first	JJ	amod
clinical	JJ	amod
result	NNS	nsubj
show	VBD	ccomp
that	IN	mark
Zubsolv	NNP	nsubj
have	VBD	ccomp
a	DT	det
66	CD	nummod
%	NN	compound
improvement	NN	dobj
in	IN	prep
bioavailability	NN	pobj
.	.	punct

(	-LRB-	punct
D.I.	NNP	dep
202	CD	nummod
at	IN	prep
58:9	CD	pobj
-	HYPH	punct
15	CD	prep
;	:	punct
D.I.	NNP	appos
211	CD	nummod
at	IN	prep
36	CD	pobj
)	-RRB-	punct
accord	VBG	prep
to	IN	prep
a	DT	det
bioequivalence	NN	compound
study	NN	pobj
,	,	punct
Zubsolv	NNP	nsubj
increase	VBZ	ROOT
the	DT	det
bioavailability	NN	dobj
of	IN	prep
buprenorphine	NN	pobj
,	,	punct
such	JJ	amod
that	IN	mark
patient	NNS	nsubj
require	VBP	advcl
a	DT	det
29	CD	nummod
%	NN	npadvmod
low	JJR	amod
dose	NN	dobj
use	VBG	acl
Zubsolv	NNP	dobj
as	IN	mark
compare	VBN	advcl
to	IN	prep
Suboxone	NNP	pobj
.	.	punct

(	-LRB-	punct
JTX	NNP	ROOT
153	CD	nummod
;	:	punct
D.I.	NNP	appos
202	CD	nummod
at	IN	prep
63:11	CD	pobj
-	SYM	punct
17	CD	prep

[	-LRB-	punct
testimony	NN	dep
of	IN	prep
Mr.	NNP	compound
Lundqvist	NNP	pobj
]	-RRB-	punct
;	:	punct
D.I.	NNP	nmod
205	CD	nummod
at	IN	prep
770:22	CD	nummod
-	HYPH	punct
771:3	CD	nmod
[	-LRB-	punct
testimony	NN	pobj
of	IN	prep
Dr.	NNP	compound
Sumner	NNP	pobj
]	-RRB-	punct
;	:	punct
D.I.	NNP	appos
196	CD	nummod
at	IN	prep
12	CD	pobj
)	-RRB-	punct
Orexo	NNP	poss
's	POS	case
pharmaceutical	JJ	amod
development	NN	compound
report	NN	nsubj
state	VBD	ROOT
that	IN	mark
"	``	punct
due	IN	prep
to	IN	pcomp
the	DT	det
anticipate	VBN	amod
improve	VBN	amod
dissolution	NN	pobj
of	IN	prep
buprenorphine	NN	pobj
the	DT	det
select	VBN	amod
dose	NN	pobj
of	IN	prep
6	CD	nummod
mg	NN	compound
buprenorphine	NN	pobj
be	VBZ	auxpass
expect	VBN	ccomp
to	TO	aux
give	VB	xcomp
approximately	RB	advmod
the	DT	det
same	JJ	amod
systemic	JJ	amod
buprenorphine	NN	compound
exposure	NN	dobj
in	IN	prep
human	NNS	pobj
as	IN	prep
a	DT	det
Suboxone	NNP	nmod
(r)	SYM	punct
tablet	VBP	pobj
with	IN	prep
8	CD	nummod
mg	NN	compound
buprenorphine	NN	pobj
"	''	punct
.	.	punct

(	-LRB-	punct
JTX	NNP	ROOT
123	CD	nummod
at	IN	prep
4	CD	pobj
;	:	punct
JTX	NNP	appos
128	CD	nummod
at	IN	prep
32	CD	pobj
;	:	punct
D.I.	NNP	appos
203	CD	nummod
at	IN	prep
352:11	CD	pobj
-	SYM	punct
22	CD	prep
)	-RRB-	punct

 	_SP	

Dist	NNP	ROOT
.	.	punct

ct	UH	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	prep
760	CD	pobj
(	-LRB-	punct
citation	NNS	nsubj
in	IN	prep
original	JJ	amod
,	,	punct
bracketed	JJ	amod
information	NN	pobj
add	VBD	ROOT
)	-RRB-	punct
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
nonetheless	RB	advmod
conclude	VBD	ROOT
that	IN	mark
the	DT	det
Zubsolv	NNP	compound
formulation	NN	nsubj
be	VBD	ccomp
obvious	JJ	acomp
.	.	punct

the	DT	det
court	NN	nsubj
cite	VBD	ccomp
Actavis	NNP	poss
's	POS	case
expert	NN	dobj
Dr.	NNP	compound
Dyar	NNP	appos
as	IN	prep
show	VBG	pcomp
that	IN	mark
"	``	punct
citric	JJ	amod
acid	NN	nsubj
be	VBZ	ccomp
pharmaceutically	RB	advmod
acceptable	JJ	acomp
,	,	punct
water	NN	npadvmod
soluble	JJ	conj
,	,	punct
and	CC	cc
of	IN	conj
the	DT	det
right	JJ	amod
size	NN	pobj
,	,	punct
so	RB	mark
therefore	RB	advmod
-PRON-	PRP	nsubj
would	MD	aux
act	VB	ROOT
as	IN	prep
a	DT	det
carrier	NN	compound
particle	NN	pobj
,	,	punct
because	IN	mark
-PRON-	PRP	nsubj
be	VBZ	advcl
in	IN	prep
the	DT	det
Suboxone	NNP	compound
tablet	NN	pobj
"	''	punct
.	.	punct

dist	JJ	ROOT
.	.	punct

ct	UH	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	ROOT
771	CD	pobj
(	-LRB-	punct
quote	VBG	pcomp
J.A.	NNP	dobj
6685	CD	nummod
,	,	punct
June	NNP	nmod
8	CD	nummod
,	,	punct
2016	CD	nummod
trial	NN	compound
tr	UH	subtok
.	.	punct
at	IN	prep
433:12	CD	pobj
-	SYM	punct
15	CD	prep
,	,	punct
ECF	NNP	compound
No.	SYM	npadvmod
204	CD	nummod
(	-LRB-	punct
Testimony	NNP	appos
of	IN	prep
Dr.	NNP	compound
Dyar	NNP	pobj
)	-RRB-	punct
)	-RRB-	punct
.	.	punct

Orexo	NNP	nsubj
point	VBZ	ROOT
out	RP	prt
that	IN	mark
Dr.	NNP	compound
Dyar	NNP	nsubj
cite	VBD	ccomp
no	DT	det
reference	NN	dobj
,	,	punct
and	CC	cc
describe	VBZ	conj
this	DT	det
reasoning	NN	dobj
as	IN	prep
"	``	punct
hindsight	NN	compound
bias	NN	pobj
,	,	punct
"	''	punct
for	IN	mark
-PRON-	PRP	nsubj
recreate	VBZ	advcl
the	DT	det
prior	JJ	amod
art	NN	dobj
from	IN	prep
the	DT	det
teaching	NN	pobj
in	IN	prep
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	pobj
.	.	punct

Orexo	NNP	nsubj
point	VBZ	ROOT
out	RP	prt
that	IN	mark
citric	JJ	amod
acid	NN	nsubjpass
be	VBZ	auxpass
nowhere	RB	advmod
use	VBN	ccomp
or	CC	cc
list	VBN	conj
or	CC	cc
suggest	VBN	conj
as	IN	prep
a	DT	det
carrier	NN	compound
particle	NN	pobj
,	,	punct
and	CC	cc
-PRON-	PRP	nsubj
be	VBZ	conj
not	RB	neg
so	RB	advmod
use	VBN	acomp
in	IN	prep
the	DT	det
Suboxone	NNP	compound
tablet	NN	pobj
.	.	punct

 	_SP	

At	IN	prep
the	DT	det
oral	JJ	amod
argument	NN	pobj
of	IN	prep
this	DT	det
appeal	NN	pobj
,	,	punct
Actavis	NNP	nsubj
concede	VBD	ROOT
that	IN	mark
no	DT	det
reference	NN	nsubj
teach	VBZ	ccomp
use	VBG	xcomp
citric	JJ	amod
acid	NN	dobj
as	IN	prep
a	DT	det
carrier	NN	compound
particle	NN	pobj
,	,	punct
or	CC	cc
that	IN	mark
citric	JJ	amod
acid	NN	nsubjpass
should	MD	aux
be	VB	auxpass
use	VBN	conj
as	IN	prep
a	DT	det
carrier	NN	compound
particle	NN	pobj
:	:	punct

 	_SP	

Actavis	NNP	compound
Counsel	NNP	ROOT
:	:	punct

-PRON-	PRP$	poss
honor	NN	npadvmod
,	,	punct
-PRON-	PRP	nsubj
will	MD	aux
confirm	VB	ROOT
what	WP	det
counsel	NN	nsubj
say	VBD	ccomp
before	RB	prep
and	CC	cc
what	WP	dobj
-PRON-	PRP	nsubj
have	VB	aux
say	VBN	conj
in	IN	prep
-PRON-	PRP$	poss
brief	NNS	pobj
.	.	punct

there	EX	expl
be	VBZ	ROOT
no	DT	det
piece	NN	attr
of	IN	prep
prior	JJ	amod
art	NN	pobj
that	WDT	nsubjpass
be	VBD	auxpass
present	VBN	relcl
that	WDT	nsubj
say	VBZ	ccomp
citric	JJ	amod
acid	NN	nsubj
be	VBZ	ccomp
a	DT	det
carrier	NN	compound
particle	NN	attr
or	CC	cc
should	MD	aux
be	VB	auxpass
use	VBN	conj
as	IN	prep
a	DT	det
carrier	NN	compound
particle	NN	pobj
.	.	punct

 	_SP	

Oral	NNP	ROOT
.	.	punct

Arg	NNP	ROOT
.	.	punct

at	IN	ROOT
21:19	CD	pobj
-	SYM	punct
21:36	CD	prep
,	,	punct
http://oralarguments.cafc.uscourts.gov/default.aspx?fl=2017-1333.mp3	NNP	npadvmod
.	.	punct

 	_SP	

court	NN	ROOT
:	:	punct

If	IN	mark
both	DT	nsubj
of	IN	prep
those	DT	det
thing	NNS	pobj
be	VBP	advcl
really	RB	advmod
well	RB	advmod
know	VBN	acomp
,	,	punct
then	RB	advmod
one	PRP	nsubj
would	MD	aux
think	VB	ccomp
that	IN	mark
if	IN	mark
citric	JJ	amod
acid	NN	nsubj
be	VBD	advcl
routinely	RB	advmod
or	CC	cc
-PRON-	PRP	nsubj
be	VBD	ccomp
obvious	JJ	acomp
to	TO	aux
use	VB	xcomp
-PRON-	PRP	dobj
as	IN	prep
a	DT	det
carrier	NN	compound
particle	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
could	MD	aux
have	VB	aux
find	VBN	ROOT
some	DT	det
reference	NN	dobj
that	WDT	nsubj
use	VBD	relcl
-PRON-	PRP	dobj
.	.	punct
...	NFP	punct

-PRON-	PRP$	poss
expert	NN	nsubj
do	VBD	aux
not	RB	neg
even	RB	advmod
testify	VB	ROOT
that	IN	mark
-PRON-	PRP	nsubj
be	VBD	ccomp
familiar	JJ	acomp
with	IN	prep
this	DT	det
industry	NN	pobj
and	CC	cc
that	IN	mark
citric	JJ	amod
acid	NN	nsubjpass
be	VBD	auxpass
routinely	RB	advmod
use	VBN	conj
as	IN	prep
a	DT	det
carrier	NN	compound
particle	NN	pobj
in	IN	prep
interactive	JJ	amod
mixture	NNS	pobj
.	.	punct

-PRON-	PRP	nsubj
just	RB	advmod
say	VBD	ROOT
-PRON-	PRP	nsubj
be	VBD	ccomp
the	DT	det
right	JJ	amod
size	NN	attr
and	CC	cc
-PRON-	PRP	nsubjpass
could	MD	aux
be	VB	auxpass
use	VBN	conj
.	.	punct

 	_SP	

Actavis	NNP	compound
Counsel	NNP	ROOT
:	:	punct

well	UH	ROOT
.	.	punct

-PRON-	PRP	nsubj
be	VBP	ROOT
right	JJ	acomp

-PRON-	PRP$	poss
honor	NN	ROOT
in	IN	prep
term	NNS	pobj
of	IN	prep
-PRON-	PRP$	poss
characterization	NN	pobj
of	IN	prep
the	DT	det
record	NN	pobj
.	.	punct

there	EX	expl
be	VBD	ROOT
not	RB	neg
citric	JJ	amod
acid	NN	attr
use	VBN	acl
as	IN	prep
a	DT	det
carrier	NN	compound
particle	NN	pobj
that	WDT	nsubj
be	VBD	relcl
in	IN	prep
the	DT	det
record	NN	pobj
.	.	punct

 	_SP	

Idaho	NNP	ROOT
at	IN	prep
26:12	CD	pobj
-	SYM	punct
26:50	CD	prep
.	.	punct

 	_SP	

Dr.	NNP	compound
Dyar	NNP	nsubj
do	VBD	aux
not	RB	neg
testify	VB	ccomp
that	IN	mark
a	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
obviously	RB	advmod
select	VB	ccomp
citric	JJ	amod
acid	NN	dobj
as	IN	prep
a	DT	det
carrier	NN	pobj
for	IN	prep
buprenorphine	NN	pobj
;	:	punct
-PRON-	PRP	nsubj
state	VBD	ROOT
that	IN	mark
if	IN	mark
-PRON-	PRP	nsubjpass
be	VBD	auxpass
select	VBN	advcl
,	,	punct
the	DT	det
artisan	NN	nsubj
would	MD	aux
expect	VB	ccomp
-PRON-	PRP	nsubj
to	TO	aux
work	VB	ccomp
.	.	punct

the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
finding	NN	ROOT
that	IN	mark
"	``	punct
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
not	RB	neg
have	VB	aux
exclude	VBN	ccomp
citric	JJ	amod
acid	NN	dobj
,	,	punct
"	''	punct
dist	JJ	npadvmod
.	.	punct

ct	UH	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	prep
773	CD	pobj
,	,	punct
be	VBZ	ROOT
not	RB	neg
a	DT	det
teaching	NN	attr
or	CC	cc
suggestion	NN	conj
to	TO	aux
use	VB	relcl
citric	JJ	amod
acid	NN	dobj
.	.	punct

see	VB	ROOT

In	IN	prep
re	IN	pobj
Gordon	NNP	pobj
,	,	punct
733	CD	nummod
f.2d	CD	nummod
900	CD	nummod
,	,	punct
902	CD	appos
(	-LRB-	punct
Fed	NNP	nsubj
.	.	punct
Cir	NNP	subtok
.	.	punct
1984	CD	npadvmod
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
the	DT	det
mere	JJ	amod
fact	NN	ccomp
that	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
could	MD	aux
be	VB	acl
so	RB	advmod
modify	VBN	acomp
would	MD	aux
not	RB	neg
have	VB	aux
make	VBN	ROOT
the	DT	det
modification	NN	nsubj
obvious	JJ	ccomp
unless	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
suggest	VBD	advcl
the	DT	det
desirability	NN	dobj
of	IN	prep
the	DT	det
modification	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

the	DT	det
record	NN	nsubj
do	VBZ	aux
not	RB	neg
contain	VB	ROOT
clear	JJ	acomp
and	CC	cc
convincing	JJ	conj
evidence	NN	dobj
of	IN	prep
a	DT	det
teaching	NN	pobj
or	CC	cc
suggestion	NN	conj
to	TO	aux
use	VB	relcl
citric	JJ	amod
acid	NN	compound
particle	NNS	dobj
as	IN	prep
a	DT	det
carrier	NN	pobj
for	IN	prep
this	DT	det
opioid	JJ	amod
product	NN	pobj
in	IN	prep
substitution	NN	compound
therapy	NN	pobj
,	,	punct
or	CC	cc
that	IN	mark
the	DT	det
actual	JJ	amod
beneficial	JJ	amod
result	NNS	nsubjpass
would	MD	aux
be	VB	auxpass
obtain	VBN	conj
.	.	punct

 	_SP	

Orexo	NNP	nsubj
also	RB	advmod
argue	VBD	ROOT
that	IN	mark
the	DT	det
specific	JJ	amod
formulation	NN	nsubj
in	IN	prep
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	pobj
preserve	VBZ	ccomp
the	DT	det
4:1	CD	nummod
ratio	NN	dobj
of	IN	prep
buprenorphine	NN	pobj
to	IN	prep
naloxone	NN	pobj
during	IN	prep
use	NN	pobj
of	IN	prep
the	DT	det
product	NN	pobj
,	,	punct
unlike	IN	prep
the	DT	det
prior	JJ	amod
art	NN	compound
product	NNS	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	ROOT
that	IN	mark
this	DT	det
benefit	NN	nsubj
be	VBZ	ccomp
irrelevant	JJ	acomp
because	IN	mark
-PRON-	PRP	nsubj
"	``	punct
go	VBZ	advcl
to	IN	prep
the	DT	det
reasonable	JJ	amod
expectation	NN	pobj
of	IN	prep
success	NN	compound
requirement	NN	pobj
,	,	punct
not	RB	neg
to	IN	aux
motivation	NN	advcl
to	TO	aux
combine	VB	xcomp
"	''	punct
.	.	punct

dist	UH	ROOT
.	.	punct

ct	UH	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	ROOT
773	CD	nummod
n.23	JJ	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
"	``	punct
there	EX	expl
be	VBZ	ccomp
nothing	NN	attr
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
which	WDT	nsubj
would	MD	aux
have	VB	aux
discourage	VBN	relcl
a	DT	det
person	NN	dobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
from	IN	prep
follow	VBG	pcomp
the	DT	det
path	NN	dobj
set	VBN	acl
out	RP	prt
in	IN	prep
the	DT	det
various	JJ	amod
reference	NNS	pobj
"	''	punct
.	.	punct

Idaho	NNS	ROOT
at	IN	prep
773	CD	pobj
.	.	punct

however	RB	advmod
,	,	punct
no	DT	det
reference	NN	nsubj
or	CC	cc
combination	NN	conj
of	IN	prep
reference	NNS	pobj
propose	VBZ	ROOT
the	DT	det
path	NN	dobj
of	IN	prep
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	pobj
.	.	punct

 	_SP	

the	DT	det
question	NN	nsubj
be	VBZ	ROOT
not	RB	neg
whether	IN	mark
the	DT	det
various	JJ	amod
reference	NNS	nsubj
separately	RB	advmod
teach	VBD	ccomp
component	NNS	dobj
of	IN	prep
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	compound
formulation	NN	pobj
,	,	punct
but	CC	cc
whether	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
suggest	VBD	conj
the	DT	det
selection	NN	dobj
and	CC	cc
combination	NN	conj
achieve	VBN	acl
by	IN	agent
the	DT	det
'	``	punct
330	CD	nummod
inventor	NNS	pobj
.	.	punct

Although	IN	mark
the	DT	det
reference	NN	poss
'	``	case
832	CD	nummod
patent	NN	nsubj
show	VBD	advcl
that	IN	mark
buprenorphine	JJ	compound
bioavailability	NN	nsubjpass
in	IN	prep
the	DT	det
film	NN	compound
formulation	NN	pobj
be	VBZ	auxpass
affect	VBN	ccomp
by	IN	agent
pH	NNS	pobj
,	,	punct
this	DT	nsubj
be	VBZ	ROOT
not	RB	neg
a	DT	det
suggestion	NN	attr
of	IN	prep
the	DT	det
sublingual	JJ	amod
tablet	NN	nmod
interactive	JJ	amod
formulation	NN	pobj
in	IN	prep
the	DT	det
'	``	punct
330	CD	nummod
patent	NN	pobj
or	CC	cc
a	DT	det
teaching	NN	conj
of	IN	prep
-PRON-	PRP$	poss
benefit	NN	pobj
in	IN	prep
deter	VBG	pcomp
abuse	NN	dobj
.	.	punct

 	_SP	

the	DT	det
reference	NNS	nsubj
show	VBP	ROOT
that	IN	mark
the	DT	det
field	NN	nsubj
of	IN	prep
opioid	JJ	amod
biopharmacology	NN	pobj
have	VBZ	aux
receive	VBN	ccomp
extensive	JJ	amod
scientific	JJ	amod
study	NN	dobj
.	.	punct

the	DT	det
'	``	punct
330	CD	nummod
patent	NN	nsubj
provide	VBZ	ROOT
a	DT	det
significant	JJ	amod
improvement	NN	dobj
.	.	punct

Despite	IN	prep
the	DT	det
extensive	JJ	amod
study	NN	pobj
,	,	punct
this	DT	det
improvement	NN	nsubjpass
over	IN	prep
the	DT	det
then	RB	advmod
-	HYPH	punct
available	JJ	amod
treatment	NNS	pobj
for	IN	prep
addiction	NN	pobj
be	VBZ	auxpass
not	RB	neg
propose	VBN	ROOT
or	CC	cc
suggest	VBN	conj
in	IN	prep
the	DT	det
reference	NNS	pobj
.	.	punct

there	EX	expl
be	VBZ	ROOT
no	DT	det
suggestion	NN	attr
that	IN	mark
the	DT	det
specify	VBN	amod
element	NNS	nsubjpass
should	MD	aux
be	VB	auxpass
select	VBN	acl
and	CC	cc
combine	VBN	conj
,	,	punct
and	CC	cc
that	IN	mark
the	DT	det
designate	VBN	amod
sublingual	JJ	amod
formulation	NN	nsubj
would	MD	aux
be	VB	conj
less	RBR	advmod
subject	JJ	acomp
to	IN	prep
abuse	NN	pobj
than	IN	prep
prior	JJ	amod
formulation	NNS	pobj
for	IN	prep
substitution	NN	compound
therapy	NN	pobj
.	.	punct

Although	IN	mark
the	DT	det
need	NN	nsubjpass
to	TO	aux
reduce	VB	acl
this	DT	det
abuse	NN	dobj
be	VBD	auxpass
know	VBN	advcl
,	,	punct
recognize	VBG	csubj
a	DT	det
need	NN	dobj
do	VBZ	aux
not	RB	neg
render	VB	ROOT
the	DT	det
solution	NN	nsubj
obvious	JJ	ccomp
.	.	punct

 	_SP	

here	RB	advmod
,	,	punct
the	DT	det
objective	JJ	amod
indicia	NN	nsubj
guide	VBP	ROOT
the	DT	det
analysis	NN	dobj
of	IN	prep
obviousness	JJ	pobj
.	.	punct

see	VB	advcl
,	,	punct
e.g.	RB	advmod
,	,	punct
Leo	NNP	compound
Pharm.	NNP	compound
Prods	NNP	subtok
.	NNP	dobj
,	,	punct
Ltd.	NNP	subtok
v.	IN	prep
Rea	NNP	pobj
,	,	punct
726	CD	nummod
f.3d	CD	appos
1346	CD	appos
,	,	punct
1357	CD	npadvmod
-	SYM	punct
58	CD	prep
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir	NNP	subtok
.	.	punct
2013	CD	npadvmod
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
This	DT	det
court	NN	nsubj
have	VBZ	aux
emphasize	VBN	ROOT
that	IN	mark
consideration	NN	nsubj
of	IN	prep
the	DT	det
objective	JJ	amod
indicia	NN	pobj
be	VBZ	ccomp
part	NN	attr
of	IN	prep
the	DT	det
whole	JJ	amod
obviousness	JJ	amod
analysis	NN	pobj
,	,	punct
not	RB	neg
just	RB	advmod
an	DT	det
after	IN	compound
-	HYPH	punct
thought	NN	appos
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	ROOT
,	,	punct
"	''	punct
the	DT	det
unexpected	JJ	amod
result	NN	nsubj
of	IN	prep
increase	VBN	amod
bioavailability	NN	pobj
provide	VBZ	ccomp
some	DT	det
support	NN	dobj
for	IN	prep
nonobviousness	NN	pobj
,	,	punct
"	''	punct
although	IN	mark
the	DT	det
court	NN	nsubj
also	RB	advmod
state	VBD	advcl
that	IN	mark
Orexo	NNP	poss
's	POS	case
long	RB	advmod
-	HYPH	punct
feel	VBN	nmod
need	NN	nsubj
and	CC	cc
copying	NN	conj
argument	NNS	dobj
"	''	punct
be	VBP	ccomp
not	RB	neg
persuasive	JJ	amod
evidence	NN	attr
of	IN	prep
such	JJ	pobj
"	''	punct
.	.	punct

dist	JJ	ROOT
.	.	punct

ct	UH	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	ROOT
776	CD	pobj
.	.	punct

the	DT	det
court	NN	nsubj
reason	VBD	ROOT
that	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
seek	VBD	ccomp
to	TO	aux
improve	VB	xcomp
bioavailability	NN	dobj
,	,	punct
that	IN	mark
interactive	JJ	amod
mixture	NNS	nsubjpass
be	VBD	auxpass
know	VBN	advcl
to	TO	aux
improve	VB	xcomp
bioavailability	NN	dobj
,	,	punct
and	CC	cc
therefore	RB	advmod
that	IN	mark
the	DT	det
improve	VBN	amod
result	NN	nsubj
of	IN	prep
the	DT	det
'	``	punct
330	CD	compound
patent	NN	poss
's	POS	case
formulation	NN	pobj
be	VBD	conj
inadequate	JJ	acomp
to	TO	aux
serve	VB	xcomp
as	IN	prep
probative	JJ	amod
evidence	NN	pobj
of	IN	prep
unexpected	JJ	amod
result	NNS	pobj
.	.	punct

see	VB	ROOT
-PRON-	PRP	subtok
would	MD	dobj
.	.	punct
at	IN	prep
774	CD	pobj
.	.	punct

 	_SP	

Orexo	NNP	nsubj
state	VBZ	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
err	VBD	ccomp
,	,	punct
for	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
do	VBZ	aux
not	RB	neg
teach	VB	advcl
or	CC	cc
suggest	VB	conj
the	DT	det
'	``	punct
330	CD	compound
patent	NN	poss
's	POS	case
formulation	NN	dobj
as	IN	prep
a	DT	det
way	NN	pobj
to	TO	aux
improve	VB	relcl
bioavailability	NN	dobj
.	.	punct

Actavis	NNP	nsubj
respond	VBZ	ROOT
that	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
be	VBZ	ccomp
silent	JJ	acomp
"	''	punct
about	IN	prep
whether	IN	mark
-PRON-	PRP	nsubjpass
would	MD	aux
be	VB	auxpass
expect	VBN	pcomp
or	CC	cc
difficult	JJ	conj
'	''	punct
to	TO	aux
increase	VB	advcl
buprenorphine	NN	amod
absorption	NN	dobj
without	IN	prep
simultaneously	RB	advmod
increase	VBG	pcomp
naloxone	JJ	amod
absorption	NN	dobj
to	IN	prep
unacceptable	JJ	amod
level	NNS	pobj
.	.	punct
'	''	punct
"	``	punct
Actavis	NNP	compound
Br	NNP	ccomp
.	.	punct
at	IN	prep
62	CD	pobj
.	.	punct

Orexo	NNP	compound
counter	VBZ	ROOT
that	IN	det
silence	NN	nsubj
be	VBZ	ccomp
not	RB	neg
a	DT	det
teaching	NN	attr
or	CC	cc
suggestion	NN	conj
;	:	punct
and	CC	cc
that	IN	mark
the	DT	det
beneficial	JJ	amod
result	NNS	nsubjpass
could	MD	aux
not	RB	neg
be	VB	auxpass
predict	VBN	conj
,	,	punct
and	CC	cc
be	VBD	conj
indeed	RB	advmod
unexpected.4	XX	acomp

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
err	VBD	ROOT
in	IN	prep
discount	VBG	pcomp
the	DT	det
enhanced	JJ	amod
bioavailability	NN	dobj
in	IN	prep
the	DT	det
'	``	punct
330	CD	compound
patent	NN	poss
's	POS	case
formulation	NN	pobj
as	IN	prep
"	``	punct
a	DT	det
'	''	punct
difference	NN	pobj
in	IN	prep
degree	NN	pobj
,	,	punct
'	''	punct
not	RB	neg
a	DT	det
difference	NN	appos
in	IN	prep
'	``	punct
kind	NN	pobj
,	,	punct
'	''	punct
"	''	punct
dist	JJ	npadvmod
.	.	punct

ct	UH	ROOT
.	.	punct

op	UH	ROOT
.	.	punct

at	IN	ROOT
774	CD	pobj
,	,	punct
for	IN	conj
the	DT	det
clinical	JJ	amod
study	NNS	pobj
report	VBN	acl
in	IN	prep
the	DT	det
'	JJ	punct
330	CD	nummod
patent	NN	compound
show	NN	pobj
66	CD	nummod
%	NN	npadvmod
improved	JJ	amod
bioavailability	NN	dobj
.	.	punct

particularly	RB	advmod
in	IN	prep
the	DT	det
context	NN	pobj
of	IN	prep
this	DT	det
invention	NN	pobj
,	,	punct
this	DT	nsubj
be	VBZ	ROOT
more	JJR	acomp
than	IN	prep
a	DT	det
trivial	JJ	amod
"	``	punct
degree	NN	pobj
"	''	punct
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
also	RB	advmod
discount	VBD	ROOT
Orexo	NNP	poss
's	POS	case
evidence	NN	dobj
that	IN	mark
Zubsolv	NNP	nsubj
be	VBZ	acl
less	RBR	advmod
susceptible	JJ	acomp
to	IN	prep
abuse	NN	pobj
than	IN	prep
Suboxone	NNP	pobj
,	,	punct
state	VBG	advcl
that	IN	mark
"	``	punct
Orexo	NNP	poss
's	POS	case
'	``	punct
real	JJ	amod
world	NN	compound
evidence	NN	nsubj
'	''	punct
set	VBN	acl
forth	RP	prt
above	RB	advmod
be	VBZ	ccomp
not	RB	neg
compelling	JJ	acomp
or	CC	cc
unrebutted	JJ	conj
,	,	punct
"	''	punct
and	CC	cc
that	IN	mark
"	``	punct
the	DT	det
only	JJ	amod
objective	JJ	amod
evidence	NN	nsubj
for	IN	prep
this	DT	det
factor	NN	pobj
be	VBZ	conj
that	IN	attr
which	WDT	nsubjpass
be	VBD	auxpass
present	VBN	relcl
to	IN	prep
,	,	punct
and	CC	cc
reject	VBN	conj
by	IN	agent
,	,	punct
the	DT	det
FDA	NNP	dep
"	''	punct
.	.	punct

Idaho	NNS	ROOT
at	IN	prep
776	CD	pobj
.	.	punct

Orexo	NNP	nsubj
state	VBD	ROOT
that	IN	det
evidence	NN	dobj
of	IN	prep
Zubsolv	NNP	poss
's	POS	case
effectiveness	NN	pobj
in	IN	prep
reduce	VBG	pcomp
abuse	NN	dobj
accumulate	VBN	acl
after	IN	prep
FDA	NNP	compound
approval	NN	pobj
,	,	punct
and	CC	cc
be	VBD	auxpass
present	VBN	conj
to	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
.	.	punct

Although	IN	mark
the	DT	det
weight	NN	nsubjpass
of	IN	prep
this	DT	det
evidence	NN	pobj
be	VBD	auxpass
dispute	VBN	advcl
,	,	punct
the	DT	det
FDA	NNP	nsubj
deem	VBD	ROOT
the	DT	det
product	NN	nsubj
worthy	JJ	ccomp
of	IN	prep
approval	NN	pobj
for	IN	prep
the	DT	det
efficacy	NN	pobj
that	WDT	nsubjpass
be	VBD	auxpass
establish	VBN	relcl
in	IN	prep
the	DT	det
clinical	JJ	amod
trial	NNS	pobj
.	.	punct

-PRON-	PRP	nsubjpass
be	VBD	auxpass
establish	VBN	ROOT
that	IN	mark
this	DT	det
novel	JJ	compound
formulation	NN	nsubj
enable	VBZ	nsubj
reduce	VBN	ccomp
dosage	NN	dobj
and	CC	cc
enhance	VBD	amod
efficacy	NN	conj
in	IN	prep
substitution	NN	compound
therapy	NN	compound
product	NNS	pobj
,	,	punct
deter	VBG	advcl
abuse	NN	dobj
.	.	punct

 	_SP	

On	IN	prep
the	DT	det
entirety	NN	pobj
of	IN	prep
the	DT	det
record	NN	pobj
,	,	punct
Actavis	NNP	nsubj
do	VBD	aux
not	RB	neg
establish	VB	ROOT
obviousness	JJ	dobj
by	IN	prep
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
.	.	punct

the	DT	det
judgment	NN	nsubjpass
of	IN	prep
invalidity	NN	pobj
be	VBZ	auxpass
reverse	VBN	ROOT
.	.	punct

-PRON-	PRP	nsubj
remand	VBP	ROOT
for	IN	prep
appropriate	JJ	amod
further	JJ	amod
proceeding	NNS	pobj
.	.	punct

 	_SP	

reversed	NN	ROOT
and	CC	cc
REMANDED	NNS	conj

 	_SP	

all	DT	det
Citations	NNPS	ROOT

 	_SP	

903	CD	nummod
f.3d	CD	ROOT
1265	CD	npadvmod
,	,	punct
128	CD	nummod
U.S.P.Q.2d	NNP	npadvmod
1034	CD	nummod

 	_SP	

Footnotes	NNP	ROOT

 	_SP	

Orexo	NNP	compound
AB	NNP	ROOT
v.	CC	prep

Actavis	NNP	compound
Elizabeth	NNP	compound
LLC	NNP	ROOT
,	,	punct
217	CD	nummod
F.Supp.3d	NNP	npadvmod
756	CD	nummod
(	-LRB-	punct
D.	NNP	compound
Delaware	NNP	appos
2016	CD	nummod
)	-RRB-	punct
(	-LRB-	punct

"	``	punct
dist	JJ	compound
.	.	punct
ct	UH	appos
.	.	punct
op	NN	ROOT
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

 	_SP	

an	DT	det
agonist	NN	nsubj
be	VBZ	ROOT
a	DT	det
chemical	NN	compound
compound	NN	attr
that	WDT	nsubj
bind	VBZ	relcl
to	IN	prep
a	DT	det
receptor	NN	pobj
and	CC	cc
activate	VBZ	conj
the	DT	det
receptor	NN	dobj
to	TO	aux
produce	VB	advcl
a	DT	det
biological	JJ	amod
response	NN	dobj
.	.	punct

partial	JJ	amod
opioid	NN	amod
agonist	NNS	nsubj
have	VBP	aux
opioid	JJ	ROOT
agonist	JJ	compound
effect	NNS	dobj
that	IN	nsubj
"	``	punct
be	VBP	relcl
less	JJR	acomp
than	IN	prep
the	DT	det
maximal	JJ	amod
effect	NNS	pobj
of	IN	prep
other	JJ	pobj
,	,	punct
'	''	punct
full	JJ	amod
'	``	punct
opioid	NN	amod
agonist	NNS	dobj
,	,	punct
such	JJ	amod
as	IN	prep
morphine	NN	pobj
,	,	punct
and	CC	cc
be	VBP	auxpass
limit	VBN	conj
by	IN	agent
a	DT	det
'	``	punct
ceiling	NN	nmod
'	''	punct
effect	NN	pobj
.	.	punct
the	DT	det
drug	NN	nsubj
thus	RB	advmod
produce	VBZ	advcl
a	DT	det
low	JJR	amod
degree	NN	dobj
of	IN	prep
physical	JJ	amod
dependence	NN	pobj
than	IN	prep
other	JJ	amod
opioid	NN	amod
agonist	NNS	pobj
,	,	punct
such	JJ	amod
as	IN	prep
heroin	NN	pobj
,	,	punct
morphine	NN	conj
,	,	punct
or	CC	cc
methadone	NN	conj
,	,	punct
and	CC	cc
be	VBZ	conj
therefore	RB	advmod
particularly	RB	advmod
useful	JJ	acomp
in	IN	prep
substitution	NN	compound
therapy	NN	pobj
"	''	punct
.	.	punct
'	''	punct
330	CD	nummod
patent	NN	dobj
,	,	punct
col.	NN	conj
9	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

19	CD	ROOT
-	SYM	punct
29	CD	prep
.	.	punct

 	_SP	

"	``	punct
opioid	NN	compound
antagonist	NNS	nsubjpass
be	VBP	auxpass
use	VBN	amod
to	TO	aux
reverse	VB	xcomp
the	DT	det
pharmacological	JJ	amod
effect	NNS	dobj
of	IN	prep
opioid	NNS	pobj
.	.	punct
selective	JJ	amod
opioid	NN	amod
antagonist	NNS	nsubjpass
,	,	punct
such	JJ	amod
as	IN	prep
naloxone	NN	pobj
,	,	punct
may	MD	aux
therefore	RB	advmod
be	VB	auxpass
use	VBN	ROOT
to	TO	aux
treat	VB	xcomp
drug	NN	compound
overdose	NN	dobj
or	CC	cc
to	TO	aux
diagnose	VB	conj
suspect	VBN	amod
opioid	NN	amod
addiction	NN	dobj
"	''	punct
.	.	punct
'	''	punct
330	CD	nummod
patent	NN	appos
,	,	punct
col.	NN	conj
col.	NN	conj
.	.	punct

 	_SP	

Actavis	NNP	nsubj
state	VBZ	ROOT
that	IN	mark
Orexo	NNP	nsubj
do	VBD	aux
not	RB	neg
argue	VB	ccomp
to	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
that	DT	mark
maintenance	NN	nsubj
of	IN	prep
the	DT	det
4:1	CD	nummod
ratio	NN	pobj
be	VBD	ccomp
an	DT	det
unexpected	JJ	amod
result	NN	attr
,	,	punct
and	CC	cc
thus	RB	advmod
that	WDT	mark
this	DT	det
argument	NN	nsubjpass
be	VBD	auxpass
waive	VBN	conj
.	.	punct

Actavis	NNP	compound
Br	NNP	ROOT
.	.	punct
at	IN	prep
61	CD	pobj
-	SYM	punct
62	CD	prep
.	.	punct

contrary	JJ	advmod
to	IN	prep
Actavis	NNP	poss
'	POS	case
statement	NN	pobj
,	,	punct
the	DT	det
record	NN	nsubj
show	VBZ	ROOT
Orexo	NNP	poss
's	POS	case
argument	NNS	dobj
that	IN	mark
"	``	punct
the	DT	det
'	``	punct
330	CD	nummod
invention	NN	poss
's	POS	case
novel	JJ	amod
structure	NN	nsubj
and	CC	cc
arrangement	NN	conj
unexpectedly	RB	advmod
improve	VBZ	acl
bioavailability	NN	dobj
over	IN	prep
the	DT	det
close	JJS	amod
prior	JJ	amod
art	NN	pobj
(	-LRB-	punct
Cairns	NNP	nmod
/	SYM	punct
Suboxone	NNP	appos
)	-RRB-	punct
,	,	punct
while	IN	mark
maintain	VBG	advcl
the	DT	det
4:1	CD	nummod
buprenorphine	NN	dobj
to	IN	prep
naloxone	JJ	amod
ratio	NN	pobj
"	''	punct
.	.	punct

Orexo	NNP	poss
's	POS	case
Resp	NNP	ROOT
.	.	punct

dist	JJ	ROOT
.	.	punct

ct	UH	ROOT
.	.	punct

br	NN	ROOT
.	.	punct

at	IN	prep
53	CD	pobj
,	,	punct
ECF	NNP	compound
No.	SYM	pobj
200	CD	nummod
;	:	punct
-PRON-	PRP	nsubj
would	MD	intj
.	.	punct
at	IN	prep
54	CD	pobj
(	-LRB-	punct
"	``	punct
the	DT	det
4:1	CD	nummod
ratio	NN	nsubj
be	VBZ	ROOT
unexpected	JJ	acomp
and	CC	cc
relevant	JJ	conj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

 	_SP	

